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Foreword
The Fourth International MELODI Workshop (www.melodi2012.org) is organized 
by STUK – Radiation and Nuclear Safety Authority in Helsinki, Finland, on 
12 – 14 September 2012.
The workshop offers an update of recent low-dose research issues, and an 
opportunity to participate in the MELODI Low Dose Research Platform, a major 
step in the long term goals that the European Low-Dose Risk research intends 
to achieve. The main goal of MELODI (www.melodi-online.eu) is to develop and 
maintain a Strategic Research Agenda (SRA) in the field of low-dose radiation 
research, and to actively promote its implementation. DoReMi Network of Excel-
lence funded by the European Commission is supporting the setting up of the 
Platform and addressing some of its research needs (www.doremi-noe.net). In 
line with one of the main SRA goals, a major aim of the workshop was to set all 
topics in an interdisciplinary context.
The Workshop abstracts cover plenary lectures as well as poster presenta-
tions related to topical discussions in breakout sessions. The theme of the first 
day “Low dose risk research – state of the art” provides an introduction to the 
MELODI activities and the SRA and an update on recent epidemiological studies 
and dosimetric aspects of low dose studies. Potential implications of cardiovas-
cular disease risk for radiation protection are also addressed. Discussion on the 
state-of-the art of MELODI SRA took place in three break-out groups addressing 
epidemiological approaches, cancer mechanisms and models and infrastructures 
and knowledge management. The second day “Emerging scientific challenges” 
features the development of science and novel technologies, covering topics such 
as epigenetics, systems biology, stem cells as well as biomarkers that could be 
potentially used in molecular epidemiological studies. The associated breakout 
sessions explore the roadmap for future research, covering themes on biomarkers 
and biobanks, non-cancer effects, as well as low dose dosimetry and dose concept. 
The third day “Integrating the research” provides highlights of Euratom projects 
dedicated for research on low dose risk. 
Prof. Sisko Salomaa, Chair of Scientific Programme Committee
Helsinki, 28th August, 2012
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Esipuhe
Säteilyturvakeskus järjestää 4. kansainvälisen MELODI Workshopin Helsin-
gissä 12. – 14. syyskuuta 2012. 
Kokous tarjoaa viimeisintä tutkimustietoa pienten annosten riskeistä 
sekä tilaisuuden osallistua MELODI-tutkimusyhteisön toiminnan kehittämi-
seen. MELODIn tavoitteena on koota yhteen eurooppalainen tutkimusyhteisö, 
joka työskentelee säteilysuojelun ja pienten annosten riskien parissa (www.
melodi-online.eu). Yhtenä MELODIn päätavoitteena on kehittää strategisen 
tutkimuksen agenda ja edistää aktiivisesti sen toteuttamista.  Euroopan komis-
sion rahoittama huippuosaamisen verkosto DoReMi tukee MELODI-tutkimus-
yhteisön perustamista ja osaltaan vastaa MELODIn strategiassa esitettyihin 
tutkimustarpeisiin (www.doremi-noe.net). MELODIn tutkimusagendan mukai-
sesti myös Helsingissä järjestettävä kokous on monitieteinen.
Kokousesitelmien tiivistelmät kattavat sekä kutsuluennot että rinnak-
kaisten työryhmien aiheisiin liittyvät posteriesitykset. Ensimmäisen päivän 
teema ”Pienten annosten tutkimuksen nykytila” sisältää katsauksen MELODIn 
tutkimusagendaan sekä viimeaikaisia tutkimustuloksia väestötutkimuksista 
ja pieniin annoksiin liittyvistä dosimetrisista kysymyksistä. Tässä yhteydessä 
pohditaan myös sydän- ja verisuonisairauksien merkitystä säteilysuojelun 
kannalta. Keskustelu MELODIn tutkimusagendan nykytilasta jatkuu rinnak-
kaisissa työryhmissä, joissa käsitellään epidemiologisia lähestymistapoja, syövän 
syntymekanismeja ja mallinnusta sekä tutkimusinfrastruktuureja ja tiedonhal-
lintaa. Toisen päivän teema “Uudet tieteelliset haasteet” käsittelee tieteellistä ja 
teknologista kehitystä, aihepiirit kattavat mm. epigenetiikan, systeemibiologian, 
kantasolututkimuksen sekä biomarkkerit, joita mahdollisesti voitaisiin käyttää 
molekyyliepidemiologisissa tutkimuksissa. Näihin liittyvät työryhmät käsitte-
levät biomarkkereita ja biopankkeja, muita sairauksia kuin syöpää sekä pienten 
annosten dosimetriaan ja annoskäsitteeseen liittyviä kysymyksiä. Kolmannen 
päivän teema, ”Tutkimuksen integraatio” sisältää katsauksia eurooppalaisiin 
tutkimushankkeisiin, jotka koskevat pienten annosten riskejä.
Prof. Sisko Salomaa, Ohjelmakomitean puheenjohtaja
Helsinki, 28. elokuuta 2012
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Institut de Radioprotection et de Sûreté Nucléaire (IRSN), DRPH-PRP, Fontenay-aux-Roses, FRaNce;  
commissariat à l’énergie atomique et aux énergies alternatives (cea), DSV, Fontenay-aux Roses, FRaNce 
The MELODI Association (“Multidisciplinary European Low Dose Initiative”) is 
a platform to coordinate and promote low dose ionizing radiation (IR) research 
in Europe with an interface to international partners. It includes 20 research 
institutions but is open to other members. The main goals of MELODI are: the 
optimization of radiation protection in Europe, promotion and development of 
sustainable R&D programs on low dose radiation health risk research, training 
and education at the European and national level along with the dissemination 
of knowledge in general, as well as to facilitate access to infrastructures, and 
provide guidance and expertise to the European Commission. The cornerstone of 
MELODI is the long-term Strategic Research Agenda (SRA), a living document 
which is regularly updated to address changing scientific and societal needs. It 
is a key element of an integrative approach to improve low dose IR health risk 
evaluation and reduce uncertainties. The scientific community is urged to help in 
establishing the framework to cope with challenges from the extended use of IR 
in industry, medical diagnostics and therapy, and radiation accidents. Currently, 
the emphasis is on research focusing on radiation-induced cancers, non-cancer 
effects, and responsiveness of individuals and normal tissues taking into account 
radiation quality, dose and dose rates, specific sensitivity of cells and tissues, and 
internal contamination. Relevant results are anticipated from the combination 
of mechanistic and suitable epidemiological studies, the use of the most recent 
scientific knowledge and technologies and integrative modelling. “Omics” and 
genetic /epigenetic profiling studies are expected to provide useful biomarkers for 
radiation exposure, detection of damage and repair, metabolic and pathological 
injuries and a better understanding of cell /tissue-specific, individual and trans-
generational responses. Analysis of metabolic and radiation-induced oxidative 
stress (and combined stresses) and intra- and intercellular signalling will help 
to clarify concepts of low dose and dose-rate responses including adaptive and 
immune responses. Ultimately, the research should lead to improved evaluation 
of low dose human health risk using systems biology approaches and modelling.
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The Life Span Study (LSS) cohort of atomic bomb survivors has been followed 
since 1950. As of the end of 2003, 58% of the 86,611 members with DS02 dose 
estimates died. The six years of additional follow-up since the last report provide 
more information (17% more cancer deaths), especially among those under age 
10 at exposure (58% more deaths). Poisson regression methods were used to 
investigate the magnitude of the radiation-associated risks, the shape of the dose 
response, and effect modification by gender, age at exposure, and attained age.
The risk of all causes of death was positively associated with radiation 
dose. The sex-averaged excess relative risk per Gy (ERR /Gy) was 0.42 for all solid 
cancer at age 70 years after exposure at age 30 based on a linear model. The 
risk was thought to increase throughout life. The ERR increased by about 29% 
per decade decrease in age at exposure and decreased in proportion to the -0.86 
power of attained age. The estimated lowest dose range with a significant ERR for 
all solid cancer was 0 to 0.20 Gy and a formal dose-threshold analysis indicated 
no threshold. Although the risk was best fit to a linear model, there were some 
fluctuations at low-dose levels, which would require further investigation. The 
risk of cancer mortality significantly increased for most major sites including 
stomach, lung, liver, colon, breast, gallbladder, esophagus, bladder, and ovary 
whereas rectum, pancreas, uterus, prostate, and kidney parenchyma did not 
have statistically increased risks. Both age effects for cancers of major sites were 
similar to those for all solid cancer, but most were not statistically significant. An 
increased risk of non-neoplastic diseases including the circulatory, respiratory, 
and digestive system was observed, but whether these are causal relationships 
requires further investigation. There was no evidence of a radiation effect for 
infectious or external causes of death.
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Epidemiological studies on natural sources 
of radiation and cancer risk
Wakeford, Richard
Dalton Nuclear Institute, The University of Manchester, Pariser Building – G Floor, Sackville Street, Manchester, M13 9PL, UK
Groups of people exposed to natural sources of ionising radiation provide an 
opportunity for epidemiological study and the potential to provide risk estimates 
to complement those obtained from groups exposed to man-made sources (e.g. 
atomic-bomb explosions and X-ray generators). Studies of underground hard-rock 
miners have provided estimates of the risk of lung cancer following inhalation 
of radon and its radioactive decay products, and this evidence has now been 
supplemented by that obtained from appropriately combining data from case-
control studies of lung cancer and residential exposure to radon and its progeny. 
The concentration, for various reasons, of other naturally occurring radionuclides 
has also led to exposure of certain groups – studies of radium luminisers and of 
patients injected with thorium-based Thorotrast have provided, respectively, clear 
evidence of excess risks of bone tumours and liver cancer. A further example of 
occupational exposure is aircrew experiencing higher levels of cosmic radiation. 
Apart from radon, a number of studies have been conducted of groups exposed to 
natural background radiation in the environment, and particular attention has 
been paid to areas where notably high γ-ray dose-rates have been found, such 
as Kerala in India and Yangjiang in China. However, these studies are difficult 
to conduct and interpret because, inter alia, the predicted risk of radiation-
induced cancer is small and controlling for major risk factors (such as smoking) 
that may be correlated with radiation exposure poses problems. One potentially 
important approach is the study of childhood leukaemia in relation to natural 
background γ-radiation: this outcome is known to be particularly sensitive to 
induction by radiation and there may be a reduced opportunity for confounding 
when compared to the study of adults. Large studies will be required to achieve 
adequate statistical power, but could show whether very low dose-rates increase 
the risk to the extent predicted.
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Review of radiation-exposed cohorts potentially 
available for molecular epidemiological studies
Cardis, Elisabeth
center for Research in environmental epidemiology (cReaL), Barcelona, SPaIN
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Radiation exposures from CT scans in childhood and 
subsequent risk of leukaemia and brain tumours
Pearce, Mark S.1; Salotti, Jane A.1; Little, Mark P.2; McHugh, Kieran3; Lee, Choonsik2;  
Kim, Kwang Pyo4; Howe, Nicola L.1; Ronckers, Cecile M.2,5; Rajaraman, Preetha2;  
Craft, Alan W.1; Parker, Louise6; Berrington de González, Amy2
1 Newcastle University, UK; 2 National cancer Institute, USa; 3 Great Ormond Street Hospital, UK; 4 Kyung Hee University, 
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Background: Although computed tomography (CT) has great clinical utility, 
serious concerns have been raised about the potential cancer risks from the 
associated ionising radiation, particularly for children. Our results for leukaemia 
and brain tumour risks from the first cohort study of CT use in children and 
young adults were reported earlier this year in the Lancet.
Methods: The cohort comprised patients without previous cancer 
diagnoses, aged < 22 years at first CT, scanned in Great Britain between 1985-
2002 and followed up to 2008. The absorbed brain and red bone marrow doses 
were estimated per scan in milligray (mGy) and analysed in relation to cancer 
outcomes using Poisson relative risk models.
results: During follow-up, 74 incident leukaemias (cohort = 178,604) and 
135 brain tumours (cohort = 176,587) were diagnosed. A significant radiation 
dose-response was found for leukaemia (p-trend = 0·010, ERR / mGy = 0.036, 
95% CI: 0.005 – 0.120) and brain tumours (p-trend < 0·001, ERR / mGy = 0.023, 
95% CI: 0.010 – 0.049). Compared to < 5  mGy the RR for a cumulative dose of 
30 + mGy (mean = 50  mGy) was 3·18 (95% CI: 1·46 – 6·94) for leukaemia and for 
50 – 74mGy (mean = 60  mGy) the RR was 2·82 (95% CI: 1·34 – 6·03) for brain 
tumours. For perspective, in children currently 5 – 10 head CTs ≈ 50mGy cumulative 
red bone marrow dose and 2 – 3 head CTs ≈ 60mGy cumulative brain dose. 
Conclusions: We found increased risks of both brain tumour and 
leukaemia with increasing dose. However, the cumulative absolute risks are 
small; approximately one excess case of leukaemia and one brain tumour per 
10,000 head CT scans by 10 years after exposure. Therefore, if the CT is clinically 
justified then the benefits should outweigh the small absolute risks. Nevertheless, 
doses should be kept as low as reasonably achievable and alternative procedures, 
which do not involve ionising radiation, should be considered if appropriate. 
Long-term follow-up is required to study the pattern of risks into the period 
when common adulthood cancers occur. 
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Biological and physical dosimetry based dose 
estimation and associated uncertainty
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Retrospective dosimetry incorporates a range of biological and physical 
techniques. The dicentric assay, which relies on the proportional relationship 
between the frequency of dicentric chromosomes in peripheral blood lymphocytes 
and radiation dose, is recognised to be the most well developed of these. The 
cytokinesis-blocked micronucleus (MN) assay is also regarded as an important 
tool for biological dose assessment. In addition, new biological indicators of dose 
are being developed, such as gene expression, protein and metabolomic markers. 
The key physical dosimetry techniques are electron paramagnetic resonance 
spectroscopy (EPR) which detects stable radicals induced by the ionisation process 
in biological or inert materials (e.g. teeth, glass), and thermally or optically 
stimulated luminescence which detects luminescence emitted by crystalline 
materials (e.g. ceramics, quartz, glass) following exposure to ionising radiation.
The ISO / IEC Guide to the Expression of Uncertainty in Measurement 
(GUM) is widely used as the fundamental reference document for uncertainty 
estimation. Nevertheless, uncertainty estimation is a constantly evolving field, 
and as such there are a number of alternative techniques which can be employed, 
not least, the powerful techniques of Monte Carlo simulation and Bayesian 
parameter estimation, which are now beginning to be exploited.
Retrospective dosimetry, and its associated uncertainty, is the focus of a 
number of current research programs. These include the EURADOS collaboration 
network, the RENEB (Realising the European Network in Biodosimetry) 
consortium and the MULTIBIODOSE project (which aims to develop multi-
disciplinary biodosimetric tools to manage high scale radiological casualties). 
These and other studies have demonstrated the importance of these techniques, 
which are used both separately and in combination, in order that accurate and 
reliable retrospective dosimetry can be carried out following a wide range of 
potential exposure scenarios.
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Uncertainties on internal dose assessment
Puncher, Matthew
Department of Toxicology, HPa centre for Radiation, chemical and environmental Hazards, chilton, Didcot, OX11 0RQ, UK 
Protection of workers and members of the public from radiation is dependent 
on the measurement and control of radiation doses. For radionuclides that have 
entered the body (internal emitters), doses are determined indirectly using 
appropriate mathematical models that describe the distribution and delivery of 
dose to body tissues over time; however, the models and their parameter values 
are subject to uncertainty. Consideration of uncertainties on internal doses is 
important for two main reasons: 
1. To assess the adequacy of internal radiation protection methodology. The 
quantification of uncertainties on internal doses can provide numerical estimates 
of the reliability of the protection quantities (equivalent and effective dose 
coefficients) used in radiation protection to assess exposures to internal emitters. 
Uncertainty analysis methods have been widely applied to quantify uncertainties 
on internal doses. Although such studies are useful for identifying important 
model parameters that affect the estimation of dose, it is not always clear how 
the distributions of effective dose that are produced by such analyses should 
be interpreted with respect to the intended use of effective dose in radiation 
protection and the use of dose coefficients as reference values. The meaning of 
“reliability” is clarified and strategies for assessing reliability using methods 
that quantify uncertainties on internal doses are discussed. 
2. To quantify risk in radiation epidemiology. Studies that estimate cancer 
risk from internal exposures are often based on point estimates of absorbed 
tissue doses that do not account for uncertainties in biokinetic and dosimetric 
models. It is becoming increasingly recognised that ignoring these can artificially 
increase the statistical power of epidemiological studies of internal exposures, 
and furthermore, can introduce bias into the estimates of cancer risk derived 
from them. Drawing on epidemiological studies that include exposures to internal 
emitters, notably plutonium exposures of Mayak workers, methodology for the 
quantification of uncertainties on doses and their effect on risk estimates is 
discussed. 
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Uncertainties related to the microdosimetry 
of internal emitters
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One of the key issues in internal dosimetry is how information on dosimetry 
and biokinetics of internal emitters can be used to improve our understanding 
of radiation-induced effects.
Low doses of incorporated radionuclides are characterized by spatially 
and temporally inhomogeneous dose distributions within a tissue or organ. The 
spatial inhomogeneity of target cells as well as the sensitivities of various cells in 
a given tissue or organ may result in different health effects. Also the temporal 
exposure inhomogeneity, that is acute, chronic or fractionated irradiation and the 
dynamic behaviour of radionuclide distribution within tissues and organs may 
affect the biological outcome. Thus average quantities like average absorbed organ 
doses may not be appropriate for the estimation of biological effects of low doses.
Important radionuclides in internal dosimetry which may require a 
microdosimetric approach are alpha and beta emitters, such as isotopes of 
plutonium and strontium in skeleton or short lived radon progenies in lungs, 
and Auger emitters, such as iodine isotopes, in the thyroid.
One of the most important issues in low dose research is the analysis and 
characterization of possible thresholds in observed health effects. Decreasing 
the dose, its role may become negligible compared to the role of confounding 
factors or compared to the repair mechanisms of cells and tissues. Another 
consequence of inhomogeneous cellular dose distribution is that modelling of 
tissue response instead of single cell responses becomes even more important 
because of interaction among adjacent cells.
Low dose effects of high and low LET radiations are quite different. High 
LET radiations reach only a small number of cells depositing a high amount of 
energy while low LET radiations affect many cells with a small amount of energy 
imparted. Thus, alternative ways of assessing high and low LET exposures should 
be investigated such as fluence, hit probability and microdosimetric energy 
distributions. Improving dosimetric quantification can decrease the uncertainty 
on the dose effect relationships.
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Implications of cardiovascular disease 
risk for radiation protection?
Jacob, Peter
Helmholtz Zentrum München, Department of Radiation Sciences, Institute of Radiation Protection, GeRMaNY
Background
High doses of ionizing radiation are well-known to increase the risk of cardiovascular 
diseases including ischemic heart diseases (IHD) and cerebrovascular disease 
(CVD). This presentation addresses the question, whether there is sufficient 
evidence for cardiovascular disease risk after whole body exposures with absorbed 
doses of several hundred milligray to be considered in radiation protection.
Risk factors and pathogenesis
Cardiovascular diseases have been associated with the interaction of several of a 
large number of risk factors including smoking, hypertension, diabetes mellitus, 
deficit of physical activity, or age. Principal steps of arteriosclerosis, a precursor 
of many cardiovascular diseases are summarized in the presentation.
Response to radiation exposure
The experimental result that low-dose exposures with a dose rate of about 1 
mGy/min lowers the risk of arteriosclerotic disease have not yet been confirmed 
by independent measurements. Different effects of moderate-dose radiation 
(100 – 1000 mGy) in heart tissue of irradiated ApoE-/- have been reported. The 
relation to cardiovascular risk is, however, still not clear.
Epidemiology for acute exposure
Analyses of the LSS cohort data with an LNT model resulted for cardiovascular 
diseases in an ERR-per-unit-dose estimate of  0.11 (95% CI: 0.05; 0.17) Gy-1. A 
multi-model analysis of the data indicates that risks at a few hundred milligray 
are lower than what is predicted by the LNT model.
Epidemiology for protracted exposure
The total of LNT analyses of about ten data sets on cardiovascular disease after 
protracted exposure indicates similar risk-per-unit-dose estimates as those for 
the LSS. There is contradictory evidence on whether or not the risk per unit 
dose at several hundred milligray is smaller than predicted by the LNT model.
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Implications for radiation protection? 
According to LNT analyses for the LSS, the ERR per unit dose for cardiovascular 
disease is lower than for cancer by a factor of 4 – 5. The number of radiation 
associated mortality cases is, however, only lower by a factor of 2 – 3. Although 
there are indications that the LNT analyses overestimate the risk at a few 
hundred milligray, cardiovascular risk should be taken into account in radiation 
protection in order to improve credibility.
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Role of epigenetic deregulation in radiation-induced  
genome and epigenome instability 
Kovalchuk, Olga
Department of Biological Sciences, University of Lethbridge, aB, caNaDa
Radiation poses a threat to the exposed individuals and their progeny. It is known 
to cause genome instability that is linked to carcinogenesis. Radiation-induced 
genome instability manifests as elevated delayed and non-targeted mutation, 
chromosome aberration and gene expression changes. Its occurrence has been 
well-documented in the directly exposed cells and organisms. 
Yet, the mechanisms by which it arises remain obscure. We hypothesized 
that epigenetic alterations play leading roles in the molecular etiology of the 
radiation-induced genome instability. Epigenetic changes comprise cytosine DNA 
methylation, histone modifications and small RNA-mediated events. 
We have established that radiation exposure profoundly alters transcrip-
tome, methylome and small RNAome of exposed cells and tissues.
The model of hierarchy and cross talk between different constituents of 
epigenetic information (DNA methylation and microRNAome), the maintenance 
and regulation of radiation responses and genome stability will be presented. The 
new model of the radiation–induced (epi)genome instability will be introduced 
and discussed.
Acknowledgements: Studies in the Kovalchuk laboratory were supported by the 
Low Dose Radiation Program/US DOE, Canadian Institutes for Health Research, 
and the Alberta Cancer Foundation.
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Epigenetic events and radiation exposure
Chakraborty, Ranajit
center for computational Genomics and Department of Forensic and Investigative Genetics, University of North Texas 
Health Science center, Fort Worth, Texas, USa
Epigenetics is broadly described as mitotic and meiotic heritable changes in 
gene expression or its potential, without any alteration in DNA sequences. 
This presentation introduces three major categories of epigenetic events (CpG 
methylation, histone tails modification, and expression of miRNA) and their 
subtypes, and provides a literature review to show the involvement of epigenetic 
factors in many disease phenotypes. Since epidemiologic data show that a 
number of such phenotypes are ionizing radiation (IR)-inducible, it is argued 
that IR-induced genome instability in exposed as well as in ‘bystander’ cells 
may be explained by epigenomic programming and alterations in cells. In 
addition, recent data are reviewed to illustrate the plausibility of the hypothesis 
of transgenerational IR-mediated effects as well as those in somatic cells being 
at least partially maintained by epigenetic mechanisms. Thus, epigenetic 
mechanisms may explain non-targeted IR-effects, as well as IR-induced health 
effects without any recognizable IR-induced sequence alterations in the genome. 
This review also indicates that the reversibility property of epigenetic changes, 
together with promotion or blocking of epigenetic events by bioactive dietary 
components, provides the prospect of ameliorating IR-induced health effects 
by chemopreventive therapies. Finally, difficulties of assessing cause-effect 
relationships of epigenetic changes and IR-induced effects are outlined, with 
possible experimental as well as modelling suggestions of such mechanisms.
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Modelling the responses of populations of cancer 
cells to therapeutic radiation exposure
Fernandez, Eric1; Orrell, David1; Fell, David1,2
1 Physiomics plc, Oxford UK; 2 Oxford Brookes University, Oxford UK
Anti-cancer therapies generally involve combinations of agents, one of which 
can be radiation treatment. Any novel agent therefore needs to be tested in 
combination with existing agents, starting with experiments on cells in culture, 
and then mouse xenograft models before testing on humans. Apart from the 
difficulties inherent in extrapolating results from one system to the next, there is 
also the problem of how to determine the most suitable order, timing and dosage of 
the different agent to achieve the best therapeutic effect. This is particularly the 
case with agents that act selectively on cells according to their phase of the cell 
cycle, as do most anticancer therapeutics, since the interactions between different 
agents depends on the interval between treatments, and can be synenergistic 
or antagonistic. It is impractical to test sufficient combinations experimentally, 
and we have therefore developed modelling approaches to allow computational 
exploration of different regimens to find optimal combinations. The Virtual 
Tumour model simulates a xenograft as a population of growing and dividing 
cells, with a core of quiescent or necrotic cells. We calibrate the model with 
experimental data including biomarker and xenograft growth curves to capture 
the effects of different agents on the duration of the phases of the cell cycle, 
and the probability of entering apoptosis from each phase. A pharmacokinetic 
model is used to predict the time-varying concentrations of drugs. In recent 
work, we have calibrated the Virtual Tumour model to simulate the responses 
of a variety of cell lines in culture to varying doses and schedules of radiation, 
and are starting to forecast the outcome of combinations of radiation treatment 
with an anti-cancer drug.
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Molecular markers in radiation-induced thyroid cancer
Zitzelsberger, Horst1; Heß, Julia1; Selmansberger, Martin1; Thomas, Gerry2; Unger, Kristian1
1 Research Unit of Radiation cytogenetics, Helmholtz Zentrum München, German Research center for environmental 
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An increased thyroid cancer risk in children and adolescents has been observed 
after the Chernobyl accident in contaminated areas even at moderate doses of 
150 mGy and below. In order to gain knowledge on radiation-associated molecular 
mechanisms in these tumors radiation biomarkers that point to deregulated 
genes and pathways need to be discovered. Several studies on post-Chernobyl 
thyroid cancers aimed to identify radiation-specific gene expression signatures 
by using gene expression arrays. A very recent study showed dose-dependent 
alterations in gene expression in post-Chernobyl thyroid cancers. We have used an 
approach in which we integrated a genomic radiation marker that we previously 
identified by array CGH with mRNA expression data of the genes located in this 
genomic region. We found an exclusive correlation of gain of the chromosomal 
band 7q11.22 –11.23 in papillary thyroid carcinomas (PTCs) from patients 
that were exposed to the Chernobyl radioiodine fallout at young age. CLIP2, 
a candidate gene from this chromosomal band was specifically overexpressed 
in the exposed cases at the mRNA and protein level (IHC) in tumours from 
exposed patients.
The novel radiation markers provide first important insights into the 
mechanisms of radiation-related carcinogenesis of young onset PTC and underpin 
the concept of radiation-specific carcinogenesis. Further validation studies on 
independent tumour cohorts are necessary for all of the published molecular 
markers. This will allow an integration of molecular markers with epidemiology 
in order to improve risk estimation for radiation-induced thyroid cancer.
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Review of biomarkers that could potentially 
be used for molecular epidemiological 
studies in radiation-exposed cohorts
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The magnitude of health risks at low doses of ionising radiation remains contro-
versial due to a lack of direct human evidence. It is anticipated that signifi-
cant insights will emerge from the integration of epidemiological and biological 
research, made possible by molecular epidemiological studies incorporating 
biomarkers and bioassays. Biomarkers can be used for multiple purposes in epide-
miological investigation including estimation or validation of received dose, of 
individual susceptibility and early detection of a radiation induced health effect. 
In the framework of the multidisciplinary work undertaken in DoReMi, we 
have reviewed ionising radiation biomarkers potentially suitable for use in large-
scale epidemiological studies. In addition to logistical and ethical considerations, 
the relevance of their use for assessing the effects of low dose ionizing radiation 
exposure at the cellular and physiological level was discussed. 
The integration of biology with epidemiology requires enhanced discussions 
between the epidemiology, biology and dosimetry communities in order to determine 
the most important questions to be addressed in light of pragmatic considerations 
including the population to be investigated, the study design, the logistics of biological 
sample collection, processing and storing, the choice of biomarker or bioassay, as well 
as the awareness of potential confounding factors. Those requirements considerably 
reduce the number of possible candidates and explain why, currently, there is no 
ideal biomarker for assessing exposure, effect or susceptibility of low dose radiation 
exposure in population studies, although some good candidates do exist. Because 
multiple end points and tissues are involved in the responses to low dose radiation, it 
is likely that a multi-marker approach will provide information about the interplay 
of different possible pathways and will be needed to evaluate an individual’s risk.
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Finding genetic susceptibility to radiation effects  
– will GWA studies help?
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There has been a veritable explosion in information from genome-wide association 
(GWA) studies that hold the promise in predicting risk of complex diseases 
and potentially radiation-associated cancers. Applying GWA study techniques 
to determine genetic susceptibility to radiation exposure would be aided by 
methods to either determine if a cancer or health outcome was truly radiation-
related or that the case group was enriched for the radiation-related outcome 
of interest. Two GWAS studies among cases and controls with high attributable 
risks for radiation-related cancers have uncovered variants in the FOXE1 gene 
in thyroid cancer and the PRDM1 gene for multiple cancers sites after Hodgkin 
lymphoma. The thyroid cancer study was conducted among those exposed in 
the Chernobyl accident and confirmed an earlier report with respect to FOXE1 
in sporadic thyroid cancer suggesting the loci’s importance with or without 
previous radiation exposure. Methods to discriminate between radiation-related 
and sporadic tumors will improve chances for discovery of radiation-specific 
variants, but these studies using e.g. gene-expression or tumor markers are 
new and promising rather than established. Genes and pathways involved in 
radiation-related cancer risk comprise a wide array of biologic processes and 
suggest that radiation susceptibility to increased cancer risk is likely polygenic 
and it may be more difficult to find many variants with small risks that interact 
collectively to appreciably account for individual susceptibility. Despite the 
complexities, technology continues to advance with the use of next generation 
sequencing methods such that whole genomes might be compared between those 
with sporadic and radiation-related cancers and unaffected individuals. While 
promising, these efforts represent applications still in their relative infancy and 
without large populations of radiation-exposed persons with biologic specimens 
in which to test them. 
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Effects of low-dose ionizing radiation on stem cells
Hildebrandt, Guido 
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In recent years, there is growing evidence for involvement of stem cells (SC) in 
cancer initiation. Because of their long life span connected with an increased 
probability to accumulate genetic damage relative to differentiated cells SC of 
normal tissue may be important targets also for radiation-induced carcinogen-
esis. Generally the knowledge about effects of radiation on SC itself and on the 
processes involved in carcinogenesis is very rare. The influence of high doses of 
ionizing radiation on SC, such as causing senescence of hematopoietic SC (Wang 
et al., 2010; Wang et al., 2011), reduction of proliferation and induction of stress-
induced premature senescence of mesenchymal SC (Cmielova et al., 2012) as well 
as induction of temporary G2 cell cycle arrest in human embryonic SC (Momcilovic 
et al., 2009) was demonstrated. The effects of moderate and low doses of IR on 
SC are very rare investigated. There are reports revealing that moderate radia-
tion doses can alter miRNAome of human embryonic SC (Sokolov et al., 2012). 
Repeated low dose ionizing radiation (LD-IR) resulted in peripheral mobiliza-
tion of bone marrow SC in diabetic rats (Guo et al., 2010). In addition LD-IR can 
cause alterations in protein expression profile of neural SC and influences neural 
differentiation (Bajinskis et al., 2011). Investigations of the effect of LD-IR on 
SC of normal tissue as possible targets for radiation-induced carcinogenesis are 
basically missing. To characterize thereby involved processes two ongoing Euro-
pean experimental studies are in progress. Both projects, EpiRadBio (FP7-269553, 
04 / 2011 – 03 / 2015) and ANDANTE (FP7-295970, 01 / 2012 –12 / 2015), do address 
radiation-induced SC responses in vitro and in vivo respectively. 
The presentation will give an overview on the current knowledge of 
radiation-induced effects on SC, paying special attention to low and moderate 
doses of IR and introduce the two ongoing European experimental studies.
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’CEREBRAD’ – Cognitive and cerebrovascular 
effects induced by low dose ionising radiation
Benotmane, M. Abderrafi
Radiobiology Unit, Belgian Nuclear Research centre, Mol, BeLGIUM
Human brain development is a protracted process that starts in early embry-
ogenesis and continues until nearly two years after birth. The brain is highly 
sensitive to ionising radiation during the foetal and early post-natal period. Data 
from atomic-bomb survivors show a 40% increase in the occurrence of mental 
retardation per Gy, with a threshold between 0.06 and 0.31 Gy foetal-dose in the 
most vulnerable gestational period: between week 8 and 15.
The CEREBRAD project aims to identify the potential cognitive and 
cerebrovascular risks of radiation doses below 100 mGy when delivered during 
development or to a young child (pre or postnatally). Health risks will be assessed 
in epidemiological studies of patients exposed in their young age to radiotherapy 
who received low doses to the brain or whose mother was pregnant or new mother 
during the Chernobyl accident. Complementary data will be gathered using 
animal models to uncover key biological and molecular mechanisms underlying 
potential cognitive and cerebrovascular effects induced by low dose radiation.
CEREBRAD will provide a stronger evidence on whether or not cognitive 
and cerebrovascular diseases can be caused from exposure to low radiation 
doses during prenatal or early postnatal periods. Hopefully, this project will help 
improve European regulations.
Acknowledgements: CEREBRAD is a collaborative European project funded in 
2011 under the 7th EU framework programme of EURATOM (GA 295552).
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SOLO: Highlights of progress to date
Haylock, Richard; Harrison John
Health Protection agency, UK
SOLO started in March 2010 and runs to September 2014. It aims to improve 
estimates of the risks of long-term health effects associated with protracted 
external and internal low dose radiation exposures, primarily through studies 
of people exposed in the Southern Urals in Russia, a group of 22,000 workers at 
the Mayak plant and a sub-group of the 43,000 offspring of the local population 
who lived near the Techa River. In addition, the feasibility is being considered of 
examining health effects in both Mayak and UK Sellafield plutonium workers.
The work packages:
1) External Dosimetry for southern Urals populations: aims to develop 
improved estimates of external doses for the two cohorts. 
progress: Work is proceeding on the validation of doses using techniques 
of Electron Paramagnetic Resonance on tooth samples and Fluorescence 
In Situ Hybridisation cytogenetics on blood samples. 
2) Epidemiological studies of Mayak Workers: aims to continue analyses 
of circulatory disease in Mayak workers, initiate analyses of chronic respir-
atory disease (CRD), and other examine cancer incidence in the cohort. 
progress: Analyses of circulatory diseases have been carried out in an 
enlarged cohort and with extended follow-up. A first analysis has been 
completed of CRD morbidity. Papers have been prepared on cancer inci-
dence in relation to plutonium exposures.
3) pooled Analysis for Mayak and sellafield plutonium workers: aims 
to consider the feasibility of an epidemiological study of cancer and non-
cancer diseases in these two groups.
progress: Following substantial delay, this study is now proceeding. 
4) Epidemiological study of cancer following in utero irradiation: 
aims to perform an epidemiological study of cancer in children born to 
women resident on the Techa river or employed at Mayak.
progress: The Techa river in utero exposed cohort has been defined and 
follow-up is progressing well. The internal dosimetry methodology for esti-
mating doses is being updated.
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DoReMi: Radiation induced premature senescence 
in endothelial cells, a system biology approach 
Harms-Ringdahl, Mats
center for Radiation Protection Research, Stockholm University, Stockholm, SWeDeN
Epidemiological studies on cohorts exposed to high doses of ionizing radiation 
have provided evidence for increased risks of cardio-vascular diseases. However, 
it is not likely that epidemiological studies will provide risk estimates for low 
dose and dose rate alone, but complemented with a mechanistic understanding 
of the cellular process induced, the gap of uncertainties may be bridged. 
In this feasibility studies, that is a part of DoReMi, WP 7 Non-Cancerous 
effects, we are aiming for a system biology approach to reveal the process 
of radiation induced premature senescence of primary endothelial cells. The 
endothelial cellular model system (HUVEC cells) is relevant for the organ at 
risk, the vascular system, and the change in phenotype to senescence is related 
to increased risks of cardio vascular disease. The study involves a wide range 
of experimental endpoints divided between seven partners where modeling as 
will serve as the link to the system biology approach. The design of the study is 
performed with the purpose to reduce inter laboratory variation and allow for 
comparisons between the partners for the endpoints selected.
In this presentation a short summary of the results and the lessons learned 
so far will be presented. 
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The SEDENTEXCT project on dental cone beam 
computed tomography: outcomes and impact
Theodorakou, Chrysoula1; Horner, Keith2; Rushton, Vivian2; Bogaerts, Ria3;  
Tsiklakis, Kostas4; Jacobs, Reinhilde5; Lindh, Christina6; Devlin, Hugh2;  
The SEDENTEXCT Consortium7
1 christie Medical Physics and engineering, The christie NHS Foundation Trust, Manchester academic Health Science 
centre, Manchester, UK; 2 School of Dentistry, University of Manchester, Manchester academic Health Science 
centre, Manchester, UK; 3 Department of experimental Radiotherapy, University Hospitals Leuven, Leuven, BeLGIUM; 
4 Department of Oral Diagnosis and Oral Radiology, School of Dentistry, University of athens, athens, GReece; 
5 Oral Imaging center, Faculty of Medicine, University of Leuven, Leuven, BeLGIUM; 6 Faculty of Odontology , Malmö 
University, Malmö, SWeDeN; 7 The SeDeNTeXcT consortium, www.sedentexct.eu
The use of Cone Beam Computed Tomography (CBCT) in dentomaxillofacial 
radiology has grown significantly over the last decade, with over 40 models 
currently on the market. However, it has been associated with higher radiation 
doses than conventional dental imaging. Most dental imaging happens in primary 
care. Furthermore, the use of dental X-ray imaging is higher in children and 
young people, so CBCT brings new challenges for radiation safety. 
The 7th Euratom Framework project SEDENTEXCT was a collaboration of 
six academic institutions and one industry partner. The aim of the project was to 
acquire key information necessary for sound and scientifically based clinical use 
of CBCT. A parallel aim was to use the information to develop evidence-based 
guidelines dealing with justification, optimisation and referral criteria and to 
provide a means of dissemination and training for users of CBCT. 
The achievements of the project so far are in several complimentary 
areas. In dosimetry, the project performed the most extensive study of different 
CBCT equipment, showing wide variations in dose and the value of field size 
limitation in dose reduction. Dosimetry and quality assurance phantoms for 
CBCT have been developed and marketed. It was demonstrated that some clinical 
uses of CBCT may have limited impact on patient management and outcomes, 
casting doubt on its use. Economic evaluation tools were developed and show 
the variation in costs of CBCT according to the healthcare context. An online 
training programme for CBCT users was devised. “Basic Principles” on the use 
of CBCT in dentomaxillofacial radiology were developed by consensus early 
in the project. A significant landmark was the development of comprehensive 
evidence-based guidelines, including a quality assurance programme for CBCT, 
recently published by the European Commission as “Radiation Protection 172”.
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ALLEGRO to ANDANTE: An application of 
radiotherapy data to low-dose radiation research
Ottolenghi, Andrea1,2; Smyth, Vere1; Trott, Klaus R.1,3 
1 Physics Department, University of Pavia, Via Bassi 6, 27100 Pavia, ITaLY; 2 INFN Section of Pavia, Pavia, ITaLY;  
3 UcL cancer Institute, University college London, UK
The ALLEGRO project was a Euratom-funded project running from January 
2009 to March 2011 investigating the medium- to long-term risk of normal tissue 
harm following radiotherapy with both current and emerging technologies. The 
workpackages included assessment of the normal tissue radiation doses outside 
the treatment volume, incidence rates and modelling methods of normal tissue 
complications, and studies modelling the incidence of second cancers following 
radiotherapy. The project led to a set of targeted recommendations to clinicians, 
manufacturers, and researchers for steps to reduce the overall risks to normal tissue 
from radiotherapy. One of the findings of the project confirmed that some treatment 
modalities (eg. high-energy x-rays > 10 MV and protons) expose normal tissue to 
a dose of neutrons that may in some cases entail significant risk of second cancer. 
However, the magnitude of the risk is unclear because of considerable uncertainty 
in the relative biological effectiveness (RBE) of neutrons in the energy range at 
which they are generated. This was seen as an important area of further research.
Acting on this recommendation, a follow-up collaborative project, ANDANTE, 
was begun in January 2012. This project takes a multi-disciplinary approach to 
investigation of the RBE of neutrons. It includes biophysical modelling of the 
initial interactions of the neutron-induced secondary charged particles with 
cellular macro-molecules, in vitro / in vivo investigation of stem cells exposed to 
neutrons over a range of energies as well as a reference beam of photons, and 
ultimately the formulation and epidemiological testing of a neutron exposure risk 
model using paediatric proton therapy data. The project intends to clarify which 
of the many published values of RBE for neutrons apply to cancer induction at 
the energies, doses, and dose-rates that are received by patients during proton 
therapy. Since the doses fall within the usual “low-dose” category the results 
will potentially have a significant impact on the more general area of radiation 
protection risk assessment from neutrons.
Acknowledgements: The research leading to these results has received funding from 
the European Atomic Energy Community Seventh Framework Programme FP7/ 2007 – 
2013 under grant agreements n° 231965 (ALLEGRO) and n° 295970 (ANDANTE).
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Colon cancer risk among a-bomb survivors  
from multi-model inference with descriptive 
and mechanistic models
Kaiser, J.C.; Meckbach, R.; Jacob, P.
Helmholtz Zentrum München, Institute of Radiation Protection, Oberschleissheim, GeRMaNY
The risk of radiation-induced colon cancer among Japanese a-bomb survivors 
has been investigated by applying both descriptive and mechanistic models to 
incidence data 1958 – 1998. Several models from both families described the data 
almost equally well. Mechanistic models are based on biologically-based (but 
still phenomenological) assumptions on the stages of carcinogenesis. To obtain 
fits to the data, which are of the same quality as those from descriptive models, 
cell processes such as a sequence of mutations in the early stage and radiation-
induced genomic instability had to be considered in mechanistic models. In 
most cases risk assessment relies on a single model, selected among descriptive 
models, which are considered as the quasi-standard in radiation protection. To 
reduce the effect of the resulting model selection bias, the method of multi-model 
inference (MMI), which is well known in other fields of research, has been recently 
introduced in radiation epidemiology. A joint is derived risk from several plausible 
models which are weighted according to the information criterion of Akaike (AIC). 
By mixing descriptive and mechanistic risk models for risk estimation markedly 
lower point estimates are obtained, compared to the estimates of the descriptive 
model with the lowest AIC value. Confidence intervals in cohort strata with low 
statistical power are increased by up to a factor of five. MMI is recommended 
in risk assessment because it provides more reliable point estimates of the risk 
and it improves the characterization of uncertainties.
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From CARDIORISK to PROCARDIO
Trott, Klaus R.1; Atkinson, Michael J.2
1 Physics Department, University of Pavia, ITaLY; 2 Institute of Radiation Biology, Helmholtz Zentrum München, GeRMaNY
The CARDIORISK project lasted from 2008 to 2011. Its aim was to investigate 
the mechanisms of both macro-vascular and cardiac micro-vascular radiation 
damage in two strains of mice after local irradiation with low, intermediate and 
high doses. High precision irradiation set-ups were deployed to reproducibly 
irradiate either the heart or selected major arteries with doses ranging from 0.2 
to 16 Gy. High radiation doses were explicitly included to investigate whether 
different mechanism are involved at low versus high radiation doses. Animals 
were sacrificed at pre-determined times for up to 60 weeks after irradiation. Since 
the animals, the heart tissue or cells were centrally prepared and provided to all 
members of the research consortium, molecular and cellular responses at different 
times could be related directly to histo-pathological and functional changes of 
the irradiated hearts. The most relevant and consistent finding was a dose and 
time dependent reduction of the microvascular density which was significant 
even at 2 Gy and which was preceded by a time and dose dependent loss of 
alkaline phosphatase expression in endothelial cells. The angiogenic capacity of 
cardiac endothelial cells and the mitochondrial function of cardiomyocytes was 
also impaired, while inflammatory, prothrombotic and adhesive markers did not 
exhibit a consistent pattern at doses less than 8 Gy suggesting that inflammation 
is not a mechanisms causing radiation-induced heart disease at low doses of 
< 2 Gy. Moreover, there was no evidence for a role of genomic changes and clonal 
expansion of damaged cells. 
A second Euratom project ProCardio (2012 – 2015) has commenced. This 
will integrate and expand ongoing European epidemiological studies of survivors 
of childhood cancer with the search for biological markers of radiation damage 
to the cardiovascular system. The ProCardio team includes clinical cardiologists, 
epidemiologists, radiation biologists, as well as proteomic and modelling experts. 
ProCardio will conduct a nested case-control investigation using individuals 
recruited specifically for the project and as part of the PanCareSurF programme. 
Dosimetric analysis of heart exposures will be performed for 16 different regions 
of the heart. Experimentally, ProCardio will identify biomarkers by exploring 
novel aspects of the mechanisms of cardiovascular damage by radiation, some of 
which were pioneered by CARDIORISK. In particular we will study the effects 
of radiation quality, dose rate, and cell-cell interactions within the cardiac 
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and endothelial environments. The new knowledge of the pathomechanisms 
will be used to develop alternative mathematical models to examine the dose 
response relationships arising from our, as well as other, epidemiological studies 
of cardiovascular effects at low doses.
41
STUK-A254UNSCEAR, BEIR VII and ICRP risk models and new developments
Radiation risk models for breast cancer 
Eidemüller, Markus
Helmholtz Zentrum München, Institute of Radiation Protection, 85764 Neuherberg, GeRMaNY
Breast cancer is the most commonly diagnosed cancer among women in most 
countries. The mammary gland is very sensitive to ionizing radiation and 
an increase of breast cancer risk after exposure has been observed in many 
epidemiological studies. Summary reports on breast cancer risk after exposure to 
ionizing radiation include e.g. BEIR VII – Phase 2 (Health Risks from Exposure to 
Low Levels of Ionizing Radiation, Biological Effects on Ionizing Radiation, 2006) 
and UNSCEAR 2006 (Effects of ionizing radiation, United Nations Scientific 
Committee on Effects of Atomic Radiation).
The knowledge about radiation-related breast cancer risk in women 
derives mainly from epidemiological studies of patients exposed to diagnostic 
or therapeutic medical radiation and of the Japanese atomic bomb survivors 
(LSS cohort). The risk models derived from the LSS cohort will be presented in 
some detail. Since the background breast cancer risk varies significantly between 
populations (Western and Asians countries) the transfer of risk estimates to other 
populations is particularly challenging for breast cancer and current approaches 
will be discussed.
Mechanistic models of carcinogenesis describe basic steps in the progress 
towards cancer. Thus mechanisms of potential non-targeted effect such as 
genomic instability can be implemented in these models and consequences for 
the radiation risk estimated. Furthermore the use of different models allows a 
more systematic estimate of model uncertainty by the method of multi-model 
inference. New approaches in these directions are presented for breast cancer 
in the LSS and the Swedish hemangioma cohort.
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Estimation of radiation risk of lung cancer
Ozasa, Kotaro
Radiation effects Research Foundation, JaPaN
Lung cancer is one of the most frequent malignancies in many countries. Tobacco 
smoking is the most prominent risk factor for lung cancer. Ionizing radiation has 
also been established as a significant risk factor of lung cancer based on many 
studies of underground miners, nuclear workers, patients therapeutically exposed 
to radiation, and the atomic-bomb survivors. Recently residential exposure 
to radon has been shown to be associated with lung cancer, especially among 
nonsmokers. Additive and multiplicative positive interactions have been observed 
between radiation and smoking.
In the atomic-bomb survivor studies, the excess relative risk (ERR) of 
radiation for lung cancer has been described as parametric functions of the form 
ρ(d)ε(s,e,a), in which ρ(d) describes the shape of the dose-response function and 
ε(s,e,a) describes the effect modification by sex, age at exposure, and attained age. 
A linear dose model (ρ(d)=βd) has generally been found to have the best fit for solid 
cancer including lung cancer and has been widely accepted. Different functions 
have been proposed to model effect modification, RERF generally uses a function 
of the form exp(τ e + υ ln(a))•σ s. The latest report indicated a significantly high 
ERR for lung cancer using the above model (sex-averaged ERR / Gy = 0.75, 95% 
CI: 0.51, 1.03 for attained age of 70 years after exposure at age of 30). The ERR/
Gy was larger for females than for males while the absolute excess risks were 
similar for both sexes. While all solid cancer and many other cancers showed an 
increase in the ERR / Gy in the subjects exposed at a young age, the effect of age at 
exposure was weak or rather inverse for lung cancer. For attained age, the ERR / Gy 
decreased with increasing age for lung cancer as well as other solid cancers. 
Interaction with smoking was also observed. Those unique aspects of radiation 
risk of lung cancer in the atomic-bomb survivors needs continued investigation.
References
UNSCEAR. UNSCEAR 2006 Report, volume I and II, 2008 and 2009.
US-NRC. Health Risks from Exposure to Low Levels of Ionizing Radiation (BEIR 
V II, Phase 2), 2006.
Ozasa K, Shimizu Y et al. Studies of the Mortality of Atomic Bomb Survivors, 
Report 14, 1950-2003: An Overview of Cancer and Noncancer Diseases. 
Radiat Res 2012; 177: 229 – 243.
43
STUK-A254UNSCEAR, BEIR VII and ICRP risk models and new developments
Preston DL et al. Solid cancer incidence in atomic bomb survivors: 1958 – 1998. 
Radiat Res 2007; 168: 1 – 64.
Furukawa K et al. Radiation and smoking effects on lung cancer incidence among 
atomic bomb survivors. Radiat Res 2010; 174: 72 – 82.
44
STUK-A254 UNSCEAR, BEIR VII and ICRP risk models and new developments
Risk models for radiation-induced leukaemia
Wakeford, Richard
Dalton Nuclear Institute, The University of Manchester, Pariser Building – G Floor, Sackville Street, Manchester, M13 9PL, UK
Leukaemia was the first cancer associated with exposure to ionising radiation 
when in 1944 March tentatively interpreted an increased leukaemia mortality 
rate in US radiologists in terms of such exposure, and in 1948 alert clinicians 
noted an excess of leukaemia among the survivors of the atomic-bombings of 
Hiroshima and Nagasaki. Since then, other epidemiological studies (mainly, but 
not solely, of those exposed for medical reasons) have reported a raised risk of 
leukaemia following exposure to radiation, and a clear link between irradiation 
and leukaemia now exists. Leukaemia risk models have been developed based 
upon data from the follow-up of the Japanese atomic-bomb survivors, supported 
by information from other studies. The dose-response has been found to be 
significantly sub-linear, a linear-quadratic model being the usual relationship 
that is supported by data. Notable age-at-exposure and time-since-exposure 
modifications of the risk are apparent in the Japanese data: following a short 
minimum latent period (on the basis of other studies, generally assumed to be 
two years) an increased risk is apparent, which is much higher among those 
exposed as children when compared to adult exposure, and this excess risk 
then attenuates with time-since-exposure. For those exposed at a young age 
in particular, the radiation-induced risk is expressed temporally as a “wave”. 
Although there is no doubt that moderate and high doses increase the risk of 
leukaemia, how the risk is influenced by low dose or low dose-rate exposures is 
more contentious. However, evidence exists for an increased risk at low levels of 
exposure, and the increase is around the magnitude predicted by models based 
upon the experience of the Japanese atomic-bomb survivors, and this evidence 
has been strengthened by recent findings. Recently developed radiation-induced 
leukaemia risk models will be presented and critically discussed, especially with 
respect to low dose / dose-rate predictions.
Poster presentations
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Correcting for measurement errors when 
estimating lung cancer risk associated with 
radon exposure among uranium miners
Allodji, R.S.1; Rage, E.1; Leuraud, K.1; Thiébaut, A.C.M.2; Henry, S.3; Bénichou, J.4; Laurier, D.1
1 Institut de Radioprotection et de Sûreté Nucléaire, IRSN/PRP-HOM/SRBe, Fontenay-aux-Roses, FRaNce; 2 INSeRM 
U657/ Institut Pasteur/Unité Pharmaco-épidémiologie et Maladies Infectieuses /Université Versailles Saint-Quentin 
ea4499, Paris, FRaNce; 3 aReVa group, Medical council, Pierrelatte, FRaNce; 4 INSeRM U657/ Department of 
Biostatistics, University of Rouen Medical School and Rouen University Hospital, Rouen, FRaNce
In epidemiological studies, Measurement Errors (ME) can substantially bias the 
estimation of the parameters. A broad variety of methods for ME correction has 
been developed, but they have been rarely applied. The present work investigates 
ME associated with radon exposure in the French cohort of uranium miners and 
its impact on the estimated excess relative risk of lung cancer death associated 
with radon exposure.
The French Cohort of Uranium Miners includes more than 5000 miners 
chronically exposed to radon with a follow-up duration of 30 years. ME associated 
with radon exposure has been characterized for each individual, taking into 
account the evolution of uranium extraction methods and that of radiological 
monitoring over time. We carried out a simulation study to investigate the effects 
of these ME on the estimated lung cancer excess relative risk per working level 
month (ERR / WLM) and to assess the behavior of different methods for correcting 
these effects.
ME associated with radon exposure decreased over time, from more than 
90% in the early 1950’s to about 10% in the late 1980’s. The type of ME also 
changed over time from mostly Berkson to classical type. Simulation results 
showed that ME leads to an attenuation of the ERR towards the null, with 
substantial bias on ERR estimates in the order of 60%. With the different ME 
correction methods considered (Substitution method, Estimate Calibration 
method, Simulation Extrapolation method), the attenuation bias was reduced 
substantially but not completely. About 50 – 60% of the bias was corrected.
This work illustrates the importance of ME correction in order to obtain 
more reliable ERR estimates of lung cancer risk associated with radon exposure 
among French uranium miners. Such risk estimates should prove of great interest 
in support to the determination of protection policies against radon. 
48
STUK-A254 Posters 1A: Epidemiological approaches 
References
Allodji RS, Leuraud K, Bernhard S, Henry S, Bénichou J, Laurier D. Assessment 
of uncertainty associated with measuring exposure to radon and decay 
products in the French uranium miners cohort. J Radiol Prot. 2012; 32 
(1): 85 – 100.
49
STUK-A254Posters 1A: Epidemiological approaches 
Monitoring of thyroid cancer incidence  
in the vicinity of nuclear sites in Belgium
Bollaerts, Kaatje1; Fierens, Sébastien1; Simons, Koen1; Francart, Julie3;  
Poffijn, André2; Sonck, Michel2; Van Bladel, Lodewijk2; Geraets, David1;  
Gosselin, Pol1; Van Oyen, Herman1; Van Eycken, Liesbet3; Van Nieuwenhuyse, An1
1 Scientific Institute of Public Health, Operational Direction Surveillance and Public Health, J. Wytsman Street 14, 
1050 Brussels, BeLGIUM; 2 Federal agency of Nuclear control, Ravenstein Street 36, 1000 Brussels, BeLGIUM; 
3 Belgian cancer Registry, Royal Street 215, 1210 Brussels, BeLGIUM
We investigated, by means of an epidemiological study, the incidence of thyroid 
cancer within the 20 km proximity area around nuclear sites, and whether there 
is evidence for an increasing thyroid cancer risk with increasing ‘surrogate’ 
exposure (residential proximity to the site, prevailing wind directions, and 
estimated discharges from the plants based on mathematical modelling) within 
the 20 km proximity area around the nuclear sites.
Results showed no increase in the incidence of thyroid cancer around the 
nuclear power plants of Doel and Tihange. Results for the Belgian territory in 
the vicinity of the French nuclear power plant of Chooz were unstable due to the 
limited number of incident cases. For the nuclear sites of Mol-Dessel and Fleurus, 
where a combination of nuclear research and industrial activities are located, 
a slightly increased incidence of thyroid cancer as compared to the regional 
average was observed, but similar and higher increased incidences were also 
seen in Belgium at other locations without nuclear sites. 
Based on the surrogate-exposure modelling, there was no evidence for an 
association between the nuclear site of Mol-Dessel and the occurrence of thyroid 
cancer, whatever the three surrogate exposure considered. In Fleurus, there was 
also no evidence for an association between the nuclear site and the occurrence 
of thyroid cancer in function of residential proximity. For prevailing winds, the 
evidence may be weakly suggestive of a potential association with the site. This 
evidence was, however, not confirmed by a further evolved modelling, i.e. the 
model of discharge estimates. This part of the analyses was hampered to a great 
extent by the large geographical areas at which health data are available.
It may be advisable to repeat the epidemiological monitoring within 
five years; to make health data available at smaller geographical level; and to 
participate in cross-border and international collaborative initiatives.
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Lung cancer mortality (1950 – 1999) among Eldorado 
uranium workers: A comparison of models of 
carcinogenesis and empirical excess risk models
Eidemüller, Markus1; Jacob, Peter1; Lane, Rachel S.D.2; 
Frost, Stanley E.3; Zablotska, Lydia B.4
1 Helmholtz Zentrum München, Institute of Radiation Protection, 85764 Neuherberg, GeRMaNY; 2 Radiation and Health 
Sciences Division, Directorate of environmental and Radiation Protection and assessment, canadian Nuclear Safety 
commission, Ottawa, Ontario, caNaDa; 3 Frost&Frost consultants, Saskatoon, Saskatchewan, caNaDa; 4 Department 
of epidemiology and Biostatistics, School of Medicine, University of california, San Francisco, USa
Lung cancer mortality risk after radon exposure among 16,236 male Eldorado 
uranium workers is analyzed with models of carcinogenesis and empirical models. 
The workers were first employed in 1932 –1980 in the Beaverlodge and Port 
Radium uranium mines and the radium and uranium refinery and processing 
facility in Port Hope, Canada, and followed up for mortality from 1950 through 
1999. A total of 618 lung cancer deaths was observed. The analysis is performed 
by means of the biologically based two-stage clonal expansion (TSCE) model and 
empirical excess risk models. Under the assumptions of the TSCE model, there is 
a strong indication that the spontaneous clonal expansion rate of premalignant 
cells is reduced at ages above about 60 years. Analysis of radiation-related 
risks shows that the principal effect for lung cancer is an increase of the clonal 
expansion rate of premalignant cells with the exposure rate. However, this 
increase is not linear as the clonal expansion rate increases strongly for low 
exposure rates and then becomes linear with a smaller slope at higher exposure 
rates. A possible explanation for this observation could be a bystander effect. In 
addition, a BEIR VI model and a parametric excess relative risk model linear in 
radon decay product exposure with attained age, time since exposure and dose 
rate as effect modifiers are investigated. The predictions of the excess relative 
risk from the different models are compared for different exposure scenarios. The 
dependence of lung cancer risk on exposure and the effect modifiers is studied 
and the uncertainty due to the use of different models is investigated.
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Domestic radon exposure and risk of childhood cancer:  
a prospective census-based cohort study from Switzerland
Hauri, D.1,2; Spycher, B.3; Huss, A.4; Zimmermann, F.5;  
Grotzer, M.6; von der Weid, N.7; Kuehni, C.E.³; Röösli, M.1,2
1 Swiss Tropical and Public Health Institute, Basel, SWITZeRLaND; 2 University of Basel, Basel, SWITZeRLaND; 
³ Institute of Social and Preventive Medicine (ISPM), Bern, SWITZeRLaND; 4 Institute for Risk assessment 
Sciences, University of Utrecht, THe NeTHeRLaNDS; 5 Department of Radiation Oncology, University Hospital, 
Basel, SWITZeRLaND; 6 Neuro-Oncology, children’s Hospital, Zurich, SWITZeRLaND; 7 Service de pédiatrie, centre 
hospitalier universitaire vaudois (cHUV), Lausanne, SWITZeRLaND
The effect of indoor radon exposure on the risk of childhood malignancies is poorly 
known. Doses from radon and its decay products are much smaller to other organs 
than to the respiratory tract and it is unclear whether they are high enough 
to cause childhood leukaemia. Until now, ecological and case-control studies 
on radon exposure and childhood leukaemia have found inconsistent results. 
Using a nationwide cohort study, we aimed to investigate whether indoor radon 
concentration is associated with an increased risk of childhood cancer in general 
and of leukaemia and central nervous system (CNS) tumours in particular.
Data on the population at risk were obtained from the Swiss National 
Cohort (SNC). All children aged between 0 and 15 years, born before the 
December 4th, 2000 (date of census) and resident in Switzerland were included. 
The follow-up period lasted from the date of census until death, emigration, 
reaching the age of 16, date of diagnosis or December 31st, 2008. Information 
on incidence cases was obtained from the Swiss Childhood Cancer Registry 
(SCCR). Radon exposure was assessed for each child based on a nationwide radon 
prediction model (Hauri, et al., 2012). We fitted Cox regression models adjusting 
for environmental radiation exposure from external sources (cosmic, terrestrial 
and artificial ground radiation), gender, birth order within each household, socio-
economic status of the parents and other potential confounders.
The mean radon concentration in the 1,300,000 children included in the 
analysis was 88.5 Bq/m³, ranging from 0.7 to 490.1 Bq/m³ (arithmetic mean). 
772 children were diagnosed with childhood malignancies of which 228 had 
leukaemia and 205 CNS tumours.
Our preliminary results do not indicate associations between residential 
radon with the risk to develop malignancies, leukaemia and brain tumour during 
infancy. 
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A record-based case-control study of natural background 
radiation and the incidence of childhood leukaemia 
and other cancers in Great Britain during 1980 – 2006
Kendall, Gerald1; Little, Mark2; Wakeford, Richard3; Bunch, Kathryn1; 
Miles, Jon4; Vincent, Timothy1; Meara, Jill5; Murphy, Michael1
1 childhood cancer Research Group, University of Oxford, New Richards Building, Old Road campus, Headington, 
Oxford, OX3 7LG, UK; 2 Radiation epidemiology Branch, National cancer Institute, DHHS, NIH, Division of cancer 
epidemiology and Genetics, Bethesda, Maryland 20852-7238, USa; 3 Dalton Nuclear Institute, The University of 
Manchester, Pariser Building – G Floor, Sackville Street, Manchester, M13 9PL, UK; 4 49 Nobles close, Grove, 
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Recently developed risk models for radiation-induced leukaemia predict that 
around 15% of childhood leukaemia incidence in Great Britain is attributable to 
natural background sources of ionising radiation. The uncertainties associated 
with this estimate are, however, substantial, not least of these being the 
appropriateness of generalising risks derived from groups briefly exposed to 
moderate and high doses (primarily the Japanese atomic-bomb survivors) to 
groups exposed at a very low dose-rate. Owing to the low cumulative red bone 
marrow (RBM) doses received in childhood from natural background radiation 
(~1.4 mSv per year), and the comparatively small geographical variation of these 
doses, large studies are required to achieve adequate statistical power to detect 
the predicted risk from this source of radiation. In the UK the comprehensive 
National Registry of Childhood Tumours, together with measurements made in 
a nationwide radiation survey, enables a suitably large study of the influence of 
external γ-ray and radon exposures upon the risk of childhood cancer, especially 
childhood leukaemia, and we have conducted such a case-control study of 27 
447 cancer cases diagnosed in Great Britain during 1980 – 2006. Cumulative 
exposures to γ-rays and radon were calculated for cases and controls using 
the maternal residence at the birth of the child. The study produced an excess 
relative risk of childhood leukaemia of 0.12 (95% CI: 0.03, 0.22) per mSv RBM 
dose from background γ-radiation, which is compatible with the predictions of 
current risk models. No statistically significant association between childhood 
cancers other than leukaemia and γ-radiation, nor between childhood leukaemia 
or other childhood cancers and radon, was found, which is consistent with prior 
evidence. At present, individual γ-ray exposures are based upon the average in 
459 County Districts (intermediately sized administrative units), but work is 
underway to improve these estimates.
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Childhood leukaemia risks:  
Towards a better understanding of unexplained results
Laurier, Dominique1; Grosche, Bernd2
1 Institute for Radiation Protection and Nuclear Safety (IRSN), FRaNce
2 Federal Office for Radiation Protection (BfS), GeRMaNY
Several published epidemiological studies of childhood leukaemia risk near 
nuclear installations recently raised questions which could not be answered 
by current knowledge on the effects of ionising radiation. In Germany, an 
increased risk of childhood leukaemia was observed in relation to the proximity 
of nuclear power plants (Kaatsch 2008). An increased risk was also observed near 
nuclear power plants in France (Sermage-Faure 2012), but this excess showed no 
association with the estimated distribution of radiation exposure due to gaseous 
discharges from the plants, and the estimated levels of exposure were far below 
the levels for which a detectable risk is foreseeable. As a consequence, the BfS 
developed an agenda for future research on childhood leukaemia in Germany 
(Ziegelberger 2010). In France, an experts group was also implemented, and 
recommendations for further actions were published (Sommelet 2011). 
Based on these recommendations, BfS and IRSN decided to hold a focussed 
workshop, bringing together the main researchers from relevant disciplines 
in the field (epidemiology, biology, dosimetry and biostatistics). This workshop 
was organised in June 2012 under the auspices of the MELODI European 
association, and regrouped more than 40 participants. The goal of the workshop 
was twofold: a) to learn from past studies and to develop a best possible study 
design for answering questions on childhood leukaemia incidence close to point 
sources; b) to identify promising directions for future research into the causes and 
pathogenesis of childhood leukaemia at a European level. The meeting’s concept 
was not focussed on radiation alone, as huge efforts have already been made in 
this field in the past years, and duplication of research should be avoided. The 
main emphasis was put on future research with interdisciplinary approaches.
The results of the workshop should provide a sound basis for developing funding 
schemes on a national and European level. 
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Mechanism of low-dose alpha particle carcinogenesis  
in 3D lung model – role of stroma-epithelial interactions
Acheva, Anna; Kämäräinen, Meerit; Lemola, Elina; Eklund, Elina; Launonen Virpi
STUK – Radiation and Nuclear Safety authority, Helsinki, FINLaND
Lung cancer is the most diagnosed cancer worldwide with 1.35 million new cases 
registered and about 1.18 million deaths each year. Smoking has been shown as 
the leading causative factor as the second place has been attributed to radon gas 
emanating to the indoor air from the ground. Epidemiological studies on radiation 
workers cohorts (Mayak workers, uranium miners) have shown dependence 
between the exposure to ionizing radiation and the lung cancer development. 
We aim to study the early effects of low dose (0.1 Gy) exposure to alpha 
particles irradiation, similar to the natural sourses of alpha radiation, using 
3D bronchial epithelial cultures EpiAirwayTM (MatTek Corp., Ashland, MA) as a 
model system. The effect of radiation on the induction of pre-cancerous changes 
was investigated by analysing the alterations in the expression of cell type specific 
markers in the normal bronchial epithelial cells. We focused on process known 
as EMT (epithelial-mesenchymal transition) which is characterized by switch of 
epithelial polarized phenotype to mesenchymal phenotype leading to loss of cell 
contacts and increased cell motility. The role of the exposure of normal tissue 
microenvironment (stroma) has also been studied and for model we used normal 
primary human fibroblasts MRC-9. They were exposed to low doses of radiation 
and co-cultured with the EpiAirwayTM tissues to allow signalling factors from 
the fibroblasts to influence the bronchial epithelial model. We studied the role 
of the TGF-β signalling in the EMT induction. The markers that we evaluated 
were epithelial (E-cadherin, β-catenin, ZO-1) and mesenchymal (fibronectin and 
vimentin). For comparison we are performing experiments on the effect from 
higher doses of radiation and also from blocking of the TGF-β signalling on the 
EMT changes in the EpiAirwayTM model.
The detailed knowledge of these mechanisms could give potential 
biomarkers for the early stages of lung cancer. Identification of stromal signalling 
involved in the EMT would give targets for early prevention of alpha particles 
induced lung carcinogenesis.
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Mechanistic insights into the hypersensitivity of 
Cockayne syndrome and Xeroderma pigmentosum 
A human fibroblasts to ionizing radiation
D’Errico, Mariarosaria1; Parlanti, Eleonora1; Iorio, Egidio2; Fattibene, Paola3; 
Pietraforte, Donatella2; Mazzei, Filomena1; Dogliotti, Eugenia1
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In a previous study we have shown that Cockayne syndrome (CS) human 
primary fibroblasts are hypersensitive to ionizing radiation (IR) and oxidizing 
agents (D’Errico et al., 2007) and present an altered redox balance (Pascucci et 
al., 2012). Here we show that the hypersensitivity of CS cells to IR is detectable 
also at doses as low as 0.5 Gy. Moreover, we provide evidence that Xeroderma 
pigmentosum (XP)-A primary fibroblasts are hypersensitive to IR (including 
low doses) and accumulate oxidative damage in their DNA upon exposure 
to oxidizing agents (Parlanti et al., under revision). To gain insights into the 
molecular mechanisms underlying the hypersensitivity of these cells to IR, the 
redox status of CS and XP-A primary fibroblasts was analysed. ROS levels were 
measured by oxidation of the spin probe CPH to CP* by EPR. The steady-state 
ROS levels were significantly higher in primary fibroblasts from both CS (A and 
B) and XP-A donors as compared to normal. This alteration was associated with a 
perturbation of the oxidative metabolism in all nucleotide excision repair (NER)-
defective fibroblasts as analysed by 1H-NMR. Experiments are in progress to 
measure ROS production after IR in normal and defective cells. To check whether 
the radiosensitivity underlies a role of these NER proteins in the processing 
of IR-induced DNA lesions, the phosphorylation of H2AX, a marker of double 
strand breaks (DSB), was measured after exposure to 0.2 and 1 Gy. A clear 
increase of gamma H2AX foci per cell was detected at both doses with higher 
levels in CS as compared to normal cells. These data confirm the sensitivity of 
the phosphorylation of H2AX as a tool to measure low dose-induced DSB and 
suggest that CS proteins participate to the processing of DSB. The role of XPA 
is currently under investigation.
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A proteomic approach to identify phase-shifts  
in responses and processes at low doses and dose rates
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The risk projection models used to estimate risk at low doses and dose rates 
derived from data found at higher levels. An accurate reflection of the processes 
that contribute to cancer risk is therefore urgently needed. It is important to 
look for any ’phase-shifts’ in the biological response to different radiation modes. 
The aim of our part (task 5.1) is to identify changes in protein regulation after 
low dose and dose rate irradiation in a selected cellular model.
Dose and dose rate effects were analyzed in human fibroblasts (VH10):
•	 Pre-irradiation only:
dose: 40 mGy; dose rate: 4.1 mGy/ h, 50 mGy/ h or 24 000 mGy/ h
•	 Pre-irradiation 2 hours prior to challenging (acute) dose: 
Pre-irradiation dose: 40 mGy , dose rates as above;
Challenging dose: 100 mGy
(Investigation of adaptive response effects)
•	 Challenging (acute) dose only: 
dose: 40 mGy, 100 mGy or 140 mGy
All challenging doses were applied with a dose rate of  24 000 mGy/ h.
Protein patterns were analyzed 3 h after exposure using the 2D-Ettan-DIGE 
system. Data of identified regulated proteins were evaluated by Western blot.
The results of the irradiation experiments provide evidence for a dose 
rate effect as demonstrated by differentially regulated proteins. A dose rate of 
4.1 mGy/ h had only marginal effects on protein regulation changes. However, a 
dose rate of 50 mGy/ h showed more regulated proteins and higher regulation 
factors than at the dose rate of  24 000 mGy/ h.
Differences in the cell response after exposure to 140 mGy in total were 
most pronounced comparing combined to single irradiation.
The data clearly show that low doses and low dose rates have different 
effects on the protein regulation in the cells. Although the protein regulation 
rates were only between 10 – 50%, the Western blots of selected proteins clearly 
confirmed regulation factors of > 0.2 found by 2D-DIGE.
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Transcription profiling of radiaoadaptive 
response in mouse thymocytes 
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A particular case of adaptive response in the thymus is the existence of an 
early radioresistance effect to thymocyte apoptosis and G1 arrest by whole-body 
preirradiation with low priming dose of 0.075 Gy before a single challenging 
dose of 1.75 Gy g-rays. However, genetic changes associated with this low dose 
radiation-induced adaptive protection response are not well understood. 
In this work, we have investigated the adaptive response of thymocytes of 
C57BL /6 mice (males and females) exposed to the mentioned adaptive regimen 
of whole-body g-irradiation to (a) determine how the priming dose influences 
subsequent transcript profiles in adapting thymocytes, and (b) identify genes that 
are associated with presence of low dose radiation-induced adaptive response 
after the challenge dose. Transcription profiles were generated from thymocyte 
RNA isolated from individual irradiated mice at 24 h and 1 week after whole-
body g-irradiation and unirradiated controls. RNA from these samples was probed 
against SurePrintG3 Mouse GE8x60K microarray (Agilent), which contains about 
60,000 mouse cDNAs. Data obtained were analyzed using the GeneSpring GX11 
software (Agilent). Preliminary data indicate that radiation-induced adaptive 
protection response of thymocytes at 24 h modulated the expression patterns of 
309 genes in females, of which 77 genes showed differential expression in both 
sexes. No differences in the expression profiles were observed when compared 
the radioadaptive reponse at 1 week and control situation. Interestingly, about 
70% of 309 genes with modulated expression in females showed time-dependent 
variation in their expression levels.
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Accumulation of DNA damage in complex normal 
tissues after protracted low-dose radiation
Schanz, Stefanie1; Schuler, Nadine1; Lorat, Yvonne1; Fan, Li1; Kaestner, Lars2;  
Wennemuth, Gunther2; Rübe, Christian1; Rübe, Claudia E.1
1 Department of Radiation Oncology and 2 Department of anatomy and cell Biology,  
Saarland University, Homburg / Saar, GeRMaNY
The biological consequences of low levels of radiation exposure and their effects on 
human health are unclear. Ionizing radiation induces a variety of lesions of which 
DNA double-strand breaks (DSBs) are the most biologically significant, because 
unrepaired or misrepaired DSBs can lead to genomic instability and cell death. 
Using repair-proficient mice as an in-vivo system we monitored the accumulation 
of DNA damage in normal tissues exposed to daily low-dose radiation of 100 
mGy or 10 mGy. Radiation-induced foci in differentiated and tissue-specific stem 
cells were quantified by immunofluorescence microscopy after 2, 4, 6, 8, and 10 
weeks of daily low-dose radiation and DNA lesions were characterized using 
transmission electron microscopy (TEM) combined with immunogold-labeling. 
In brain, long-living cortical neurons had a significant accumulation of foci with 
increasing cumulative doses. In intestine and skin, characterized by constant cell 
renewal of their epithelial lining, differentiated enterocytes and keratinocytes 
had either unchanged or only slightly increased foci levels during protracted 
low-dose radiation. Significantly, analysis of epidermal stem cells in skin revealed 
a constant increase of 53BP1 foci during the first weeks of low-dose radiation 
even with 10 mGy, suggesting substantial accumulations of DSBs. However, 
TEM analysis suggests that the 53BP1 foci are not persistently unrepaired 
DSBs because they do not co-localize with activated Ku70 or DNA-PKcs, core 
components of non-homologous end-joining. In contrast, our findings suggest that 
these lesions, which are predominantly located in compact heterochromatin, may 
reflect permanent chromatin rearrangements caused by the repair or misrepair 
of radiation-induced DSBs. 
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Gamma irradiation facility for low dose / dose rate  
in vitro biological studies
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Pecchia, Ilaria1; Tabocchini, Maria Antonella1,2 
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We present a gamma irradiation facility for the exposure of cultured mammalian 
cells to dose rates ranging from few μGy/ h to some tens of mGy/ h. The study of 
the effects of these low dose rates have important implications both in radiation 
protection and in therapy (late response of healthy tissues). The irradiating 
system has been designed at the Istituto Superiore di Sanità (ISS), and, as of 
June 2012, is in the phase of construction. The realization of the facility has been 
made possible by a special EU funding, through a dedicated task, “LIBIS”, of the 
EURATOM Network of Excellence “DoReMi” (7th FP). 
Three especially designed holders will house, respectively, three 137Cs 
sources with different activities, 37 MBq, 740 MBq and 18.5 GBq, forming three 
irradiators. Depending on the dose rate required by the experiment, one of the 
irradiators and the cellular sample will be placed inside a shielded incubator with 
controlled temperature, humidity and CO2 atmosphere. The distance between the 
irradiator and the sample will be adjusted to have the chosen dose rate on the 
sample. The dose rate uniformity on the sample will be at least of 95%, and the 
percentage of 662 keV (energy of the photon released in the 137Cs decay) photons 
impinging on the sample will be greater than 80%. Geant4 simulations will be 
performed in order to evaluate the dose delivered to the cells. The dose rate at 
sample position will also be measured before the experiments using different 
dosimeters (TLD, OSL, alanine and /or ionization chamber).
The main issues that will be possible to tackle with this irradiation facility 
are: i) comparison of the effectiveness of low dose rate chronic exposures vs acute 
exposures, using the 137Cs gamma cell of the ISS; ii) comparison of low dose rate 
exposures as a function of radiation quality, made possible by the alpha particle 
irradiator developed at the ISS; iii) sequential irradiation studies irradiating 
the same sample with the two radiation types.
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The PTB microbeam facility
Giesen, Ulrich; Langner, Frank
Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116 Braunschweig, GeRMaNY
This microbeam facility has been in routine operation for the last 10 years 
and irradiations of various cell types have been carried out for a variety of 
collaborative projects with outside groups. The microbeam provides high-LET 
αparticles and low-LET protons with energies of 3 MeV to 20 MeV. This range 
of ions and energies allows the selection of radiation qualities with LET values 
between 3 keV/µm and 200 keV/µm, which covers almost entirely the range 
from diagnostic X-rays to naturally occurring α-radiation. The cell nucleus or 
cytoplasm of individual cells can be targeted with a spatial resolution of about 
2 µm and irradiated with a single particle or with precisely counted multiple 
particles. For the study of bystander effects one can choose to target selected 
cells or a fraction of cells in a dish and study the radiation response in directly 
irradiated and bystander cells (Frankenberg et al., 2008). At present, up to 50,000 
cells per hour can be automatically processed including all experimental steps 
(imaging, cell recognition, position analysis and irradiation). The use of reference 
markers allows the revisiting of each cell in a dish for later analysis of radiation 
responses using a variety of endpoints. Live-cell imaging of GFP- or RFP-tagged 
reporter genes has been established at PTB (Mosconi et al., 2011) and is readily 
available.
Irradiations in neutron fields with energies in the range of 0.1 MeV to 
15 MeV are available at the PTB ion accelerator facility (Frankenberg et al., 
2010; Schmid et al., 2003).
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STORE – a data-sharing infrastructure for radiobiology 
as a tool for knowledge management
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The sharing of data and biomaterials from publicly funded experimental radiation 
science adds enormous value to the original investment. Sharing will yield 
substantial scientific added value through re-analysis and new investigations. 
This does not only account for new technologies in data analysis. Moreover, 
the rapid progress in radiation biology allows analysing old material with new 
techniques.
The emergence of ’omics technologies has led to an explosion in the rate 
and volume of data generation, and data sharing through the scientific literature 
alone has become impossible. It is well recognised in the community that potential 
benefits can accrue from a wider culture of sharing to date’s research data and 
bio resources by making data available immediately on publication and resources 
within a defined period. But also the use of legacy data is particularly important 
for radiation biology, because a large number of studies conducted between the 
1950s and ’90s are unrepeatable because of ethical and financial restrictions. 
Still, such legacy data can usefully be reanalysed in the light of new paradigms 
(Schofield et al., 2010).
Thus, it is not only important to rescue endangered primary data, even 
more crucial is to archive it at the time it is generated. This lesson has been 
learned by the radiobiology community, who took on that challenge 25 years ago 
when developing the International Radiobiological Archives, with was further 
developed to become the internet-based data repository ERA (Birschwilks et 
al., 2011).
For both purposes, rescuing endangered data from past experiments and 
saving data from modern studies, the STORE infrastructure has been developed. 
STORE allows the storage and retrieval of data from past, current and future 
radiobiological studies. Secure access software allows full control for the data’s 
originator: information can be stored only, e.g. as a backup, without access for 
others; it can be made available to selected co-workers; it can be released to 
the whole scientific community. STORE can also act as a directory to physical 
collections of tissue samples, FFPE blocks, and slides etc. or to other relevant 
data bases, e.g. of the German Uranium Miners Cohort Study. For slides, STORE 
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offers the possibility of hosting whole histopathology slide scans as a virtual 
archive. It has to be emphasised that STORE is suitable for both information from 
radiobiological experiments and for studies amongst human populations. As an 
example, STORE hosts the data of the German Thorotrast study – a cohort study 
amongst Thorotrast patients –, the data of the respective animal experiments 
and a pointer to biomaterial from these experiments.
Knowledge management does not only imply making data and biomaterial 
available. Information will only turn into knowledge if it is linked to an action 
or to a thought-process, though information is the necessary first step. To allow 
for extracting the utmost information from a platform like STORE experiences 
made by others based on the same information has be made available. To that end, 
STORE is also capable to include annotations to the information, give references 
to scientific publications or incorporate grey literature like lab reports. This has 
been done successfully in ERA (http://era.bfs.de). 
In our case, knowledge management also includes the development of 
Standard Operating Procedures (SOP) for evaluating the quality of radiobiological 
archive tissue and defining test systems describing the usefulness of such 
material. The resulting data have been quantified and the procedures performing 
best in terms of the call rates of data points and experimental noise, compared 
to those from the fresh-frozen or freshly-made formalin-fixed paraffin-embedded 
(FFPE) control, have been validated. The SOPs have been made available 
(Azimzadeh et al., 2010; 2011; 2012). Last but not least, new methods appeared 
during the course of the project. It has been shown that these methods can also 
be used for archival material (Paunesku et al., 2012).
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RENEB – Realizing the European 
Network of Biological Dosimetry
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18 LaFe, SPaIN; 19 UNITUS, ITaLY; 20 NcSR D, GReece; 21 INSP, POLaND; 22 eNea, ITaLY; 23 UGent, BeLGIUM
RENEB will establish a sustainable network of biological dosimetry, including 23 
organisations from 16 EU-countries. It will significantly improve the accident and 
emergency response capabilities in case of a large-scale radiological emergency 
by contributing highest efficiency in the processing and scoring of biological 
samples for a fast and reliable dose reconstruction. The operational basis will 
comprise the analysis of acknowledged biomarkers for radiation exposure. Six 
applied techniques will be compared, standardized and harmonized within the 
partner laboratories to guarantee the highest possible reliability and accuracy 
of the dose estimation. Beyond the use for emergency cases, the network with 
its capability to jointly analyse large numbers of samples will also be able to 
contribute to a wider field of radiation research, e.g. to studies focusing on topics 
like radiation effects in the low dose range, individual-, age- or sex-related 
radiosensitivity or internal radiation exposure. The safeguard of the high quality 
and education & training provisions standard will be ensured by implementing 
a Quality Assurance & Quality Management (QA&QM) program. This will 
include a long-term training program with technical exercises according to the 
requirements of international standards and performed on a regular basis. This 
program is intended to be linked to already existing European and global training 
platforms such as those supported by ENEN, ENETRAP, ENSTTI and IAEA. 
Besides the training of the laboratory staff, also the testing and validation of new 
bioindicators will be performed. RENEB will thus contribute in manifold way 
to the needs of the radiation research community. In this regard, an interaction 
with radiation research platforms such as MELODI is envisaged.
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In vivo gene expression studies confirm differential 
expression profiles at low doses of ionizing 
radiation when compared to in vitro ones
El-Saghire, Houssein1,2; Thierens, Hubert1; Michaux, Arlette1; 
Vandevoorde, Charlot2; Willems, Petra3; Baatout, Sarah1
1 Radiobiology Unit, Belgian Nuclear Research centre, ScKceN, Mol, BeLGIUM; 2 Faculty of Life Sciences and 
Medicine, Ghent University, BeLGIUM; 3 Federal agency for Nuclear control, Brussels, BeLGIUM
A lot is known about the effects of high doses of ionizing radiation, but till now, 
there is a lack of clear and coherent information on the health effects of low 
doses. This is a matter of great importance, especially considering the increased 
individual and societal radiation burden caused by medical imaging that incor-
porates the use of X-rays.
When studying ionizing radiation, especially in the low dose region, we are 
faced with the limitation of technique sensitivity, except for γ-H2AX foci. DNA 
microarrays are widely utilized to study cellular responses of complex nature and 
previous studies have shown that microarrays are effective in the determination 
of pathways and genes that can be induced by ionizing radiation. In our study, 
we examined the global gene expression profiles of whole blood samples before 
and after exposure to a typically low and high X-irradiation dose (0.05, and 
1 Gy), at a rate of 30 mGy/min (250 kV, 1.6 mA, 1 mmCu). We investigated the 
gene expression profiles after 8 hours. Gene Set Enrichment Analysis (GSEA) 
revealed two distant dose-dependent profiles. In contrast to high doses, we found 
that a low dose of 0.05 Gy showed higher statistical ranking of immune-related 
pathways that are mainly involved in response and /or secretion of growth factors, 
chemokines and cytokines. This response is typically related to bystander effects 
and tissue response. At 1 Gy however, the response was dominated by classical 
radiation response genes including tumor suppressor TP53, apoptosis, DNA 
damage and repair.
In order to validate our in vitro conclusions we moved to an in vivo study. 
Blood samples were collected from prostate cancer patients undergoing arc 
therapy before and 24 hours after the first fraction of radiotherapy. Dosimetric 
calculations showed that the circulating blood of these patients received a dose in 
the range 0.03 – 0.1 Gy. RNA was isolated and DNA microarrays were performed 
on a total of 7 patients. We found 890 genes that were significantly modulated 
between controls and irradiated samples (FDR < 5%). Pathway enrichment 
analysis showed the involvement of the significant genes in immune modulation, 
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cytokine secretion, DNA damage, and cell cycle regulation / check points. Some 
of these genes (XRRC4, BMX, and TNFAIP6) were confirmed using qRT-PCR. 
GSEA analysis revealed similar pathways as observed in the individual gene 
list analysis, with more emphasis on the involvement of certain immune related 
pathways such as toll-like receptors and MAPK. Both in vitro and in vivo results 
show that low doses of ionizing radiation can induce an immune response 
involving intercellular communication and probably elicits increased radiation-
induced damage.
Acknowledgements: This work is supported by the Federal Agency of Nuclear 
Control (FANC-AFCN, Belgium).
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EU EPI-CT project:  
biomarkers of radiation sensitivity for children
El-Saghire, Houssein1,2; Vandevoorde, Charlot2; Thierens, Hubert2;  
Michaux, Arlette1; Oestreicher, Ursula3; Roessler, Ute3; Kulka, Ulrike3;  
Gomolka, Maria3; Lindholm, Carita4; Haghdoost, Siamak5; Fernet, Marie6;  
Hall, Janet6; Pernot, Eileen7; Kesminiene, Ausrele8; Baatout, Sarah1
1 Belgian Nuclear Research centre, ScKceN, BeLGIUM; 2 Ghent University, BeLGIUM; 3 Federal Office for Radiation 
Protection, BfS, GeRMaNY; 4 Radiation and Nuclear Safety authority, STUK, FINLaND; 5 centre for Radiation 
Protection Research, Stockholm University, SWeDeN; 6 Institut curie, FRaNce; 7 centre for Research in environmental 
epidemiology, cReaL, SPaIN; 8 International agency on Research against cancer, FRaNce
In the last 10 years the use of computed tomography (CT) has grown considerably. 
As a result, the numbers of examinations have increased to the extent that CT 
has made a substantial impact on not only patient care, but also patient and 
population exposure from medical X-rays. This relatively high dose modality 
contributes up to 60% of the collective dose from diagnostic radiology in some 
European countries. The increasing use of paediatric CT worldwide has raised 
the question of possible late effects from exposure to ionising radiation. The 
European collaborative EPI-CT project (Epidemiological study to quantify 
risks for paediatric computerized tomography and to optimise doses) 
aims at studying the cancer risks and the underlying biological effects in an 
international cohort study. The project is coordinated by the International Agency 
for Research on Cancer (IARC). The overall objective is to inform about dose 
reduction and optimisation in paediatric CT.
The aim of the biological part of the study (Workpackage 5) is to compare 
in vitro and in vivo different biomarkers for radiation exposure and to test their 
sensitivity in clarifying the biological mechanisms behind low dose hypersensitivity 
observed in CT examined paediatric patients. The work is divided into a number 
of distinct and complementary tasks which will allow studying the effects of CT 
exposure using a variety of approaches, including assessment of DNA damage 
(through monitoring chromosomal aberrations and gamma H2AX foci), oxidative 
stress, gene expression and inflammatory response.
Final results of this pilot study will be used for evaluating the feasibility 
of conducting a larger study allowing sufficient statistical power for estimation 
of age- and sex-dependent radiosensitivity.
Acknowledgements: This work is supported by the EU EPI-CT grant agreement 
(n° 269912).
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Low dose IR induces gene expression changes 
via DNA breaks and other pathways
van Gent, Dik1; Leite, Ricardo1; Swagemakers, Sigrid1; van Heijningen, Paula1; 
Garinis, George A.1; Sutmuller, Marjolein2; Kanaar, Roland1; Essers, Jeroen1
1 Dept. of cell Biology & Genetics, cancer Genomics centre, erasmus Mc Rotterdam, THe NeTHeRLaNDS;  
2 Nuclear Research and consultancy Group , Department of Radiation & environment, Petten, THe NeTHeRLaNDS
The effects of low and protracted doses of ionizing radiation on humans are only 
partially understood. The shape of the dose response curve at low and protracted 
doses cannot be measured accurately using standard epidemiological methods. 
However, this information is needed for rationale policy decisions for setting 
exposure limits. Therefore, we set out to determine a gene expression signature 
that operates at low and intermediate doses using a panel of DNA double strand 
break repair deficient mouse models.
We developed mouse models that lacked one or both of the major DNA 
double strand break repair pathways (nonhomologous end-joining and homologous 
recombination) and compared transcriptional responses in these DNA repair 
deficient mice with normal mice before and after irradiation with a relatively low 
dose of gamma radiation (200 mGy). Importantly, the changes in gene expression 
patterns were nearly identical in repair-deficient mice and in irradiated mice. We 
identified a gene expression signature that was very similar, but considerably more 
pronounced (up to 5-fold) in irradiated DNA repair deficient mice compared to normal 
mice, showing that the transcriptional responses are indeed caused by the DNA 
damage inflicted by radiation and that DNA repair deficient mice can be used as 
the proverbial ‘canary in the coalmine’ in the context of low dose radiation research. 
The identified gene expression signature includes Gadd45a, Gad45b, MDM2, BAG3, 
and CDKN1A (p21) and in addition allowed the identification of additional genes by 
correlation analysis. A distinct set of genes was consistently upregulated after low 
dose IR, but this did not change with DSB repair defects, suggesting that this part 
of the transcriptional responses is caused by other triggers than DSBs. 
We conclude that this transcriptional response can be used as a very 
sensitive read out for low levels of radiation exposure. This will be meaningful, 
as several genes from this signature have functions in known pathways that 
regulate cell proliferation and /or senescence and apoptosis, which are all relevant 
for carcinogenesis and (tissue) aging. This consistent gene expression signature 
defines a universal marker profile relevant for the general population, providing 
valuable tools for biomarkers, mechanistic understanding, prevention and therapy.
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The German Uranium Miners Biobank  
– current status and perspectives in radiation research
Gomolka, M.1; Danescu-Mayer, J.1; Otten, H.2; Johnen, G.3; Pesch, B.3; Lehnert, M.3; Taeger, D.3;  
Wiethege, T.3; Möhner, M.4; Gellissen, J.4; Wichmann, E.5; Kulka, U.1; Kreuzer, M.1
1 Federal Office for Radiation Protection, GeRMaNY; 2 German Social accident Insurance (DGUV), GeRMaNY;  
3 The Institute for Prevention and Occupational Medicine of the German Social accident Insurance (IPa), GeRMaNY; 
4 Federal Institute for Occupational Safety and Health (Baua), GeRMaNY; 5 Institute of epdidemiology I, GeRMaNY
The German uranium miners of the former Wismut mining company with about 
400,000 employees are the largest radiation exposed miner population worldwide. 
59,000 of them are included in the Wismut Cohort Study. Yet, biobanks from occupa-
tionally radiation exposed individuals do not exist or only on a small scale. Together 
with the German Social Accident Insurance (DGUV) and its research institute the 
IPA, the Federal Institute for Occupational Safety and Health (BAuA) and the Insti-
tute of epidemiology of the HMGU, the BfS collected blood from 442 healthy workers 
and from 81 workers with lung cancer. Additionally, DNA and RNA from tissue 
of lung cancer cases from the Wismut Autopsy Archive and blood from children of 
Wismut miners whose fathers died early on lung cancer was collected. The biological 
material and the epidemiological and experimental data are stored in the German 
Uranium Miners Biobank at the BfS. The data will be available via STORE.
From 2009 to 2011, 442 healthy volunteers were recruited for sample 
collection. 292 of the probands received a cumulative radon exposure of more than 
750 Working Level Month (WLM), 150 probands less than 50 WLM. Blood was 
collected for isolation and cryoconservation of DNA, RNA, lymphocytes and plasma 
proteins. The samples were processed according to established SOPs and finally 
stored in the biobank at the BfS. A quality check on several molecular levels (DNA 
methylation, SNPs, mRNA, miRNA, and protein) confirmed the suitable quality of 
the SOPs. Detailed data on occupational exposure to radiation, dust and arsenic 
as well as health and smoking data are available. DNA from 250 tissue samples of 
lung cancer cases and RNA from a subset of 50 samples, tumor tissue and normal 
tissue, was extracted. Genome wide array data (Illumina 660K chip) were generated 
from DNA from additional 81 lung cancer cases. DNA, lymphocytes and plasma 
were extracted from blood of 87 children whose fathers died of early lung cancer. 
The biobank will contribute to systembiological research projects to investigate 
genetic, biochemical and metabolic factors in dependence of occupational radiation 
exposure and life style. It will be a powerful tool to analyse radiation risk at low 
doses, individual susceptibility to radiation, long term radiation exposure markers 
and radiation specific fingerprints in lung cancer.
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Proteomics profiling of low molecular weight plasma 
proteins from locally irradiated individuals
Nylund, Reetta1; Lemola, Elina1; Hartwig, Sonja2; Lehr, Stefan2;  
Acheva, Anna1; Jahns, Jutta3; Hildebrandt, Guido4; Lindholm, Carita1
1 STUK – Radiation and Nuclear Safety authority, FINLaND; 2 DDZ – Deutsches Diabetes, GeRMaNY;  
3 Department of Radiotherapy and Radiation Oncology, University of Leipzig, GeRMaNY; 4 Department  
of Radiotherapy, University of Rostock, GeRMaNY
Blood plasma from radiation exposed individuals has been shown to induce 
chromosome damage when transferred into lymphocyte cultures of non-irradiated 
persons. The nature of these clastogenic factors (CF) is still mostly unknown, 
although evidence exist that some of them are low molecular weight (LMW) 
proteins. In the current work, we have applied proteomics techniques to profile 
some potential CFs in plasma samples of locally exposed clinical patients.
Ca 30 patients obtaining fractionated treatment were sampled: before the 
first fraction and directly after last irradiation fraction was delivered. Three 
patient groups, receiving characteristic treatment regime, were studied: marginal 
resected basal cell carcinoma, painful osteoarthritis of the knee and painful 
tendinitis of the elbow/ heel. Control group consisted of ten healthy individuals 
and a positive control group of three radiation accident victims was also included. 
Plasma samples were pre-treated to enrich LMW proteins. Proteins were 
analyzed using two dimensional difference gel electrophoresis (2DE-DIGE). No 
differences were observed in protein expression due to local radiation exposure 
(before vs. after) in any of the patient groups. The expression of a few proteins was 
shown to diverge between groups only with respect to previous steroid treatment 
(treated vs. non-treated: t-test p < 0.01, fold ratio > ±1.5). However, plasma from 
the radiation accident victims showed alterations in the expression of 19 proteins 
(t-test with FDR correction, p < 0.05, fold ratio > ±1.5) in comparison to the plasma 
from control group. Proteins included e.g. haptoglobin and serotransferrin. 
However, these molecules are not among the potential proteins to function as CFs.
In summary, proteomics analysis showed that local radiation treatment 
did not have detectable effects on protein expression levels in any of the patient 
groups, whereas differences were observed in the radiation accident victims in 
comparison to controls.
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Healthy tissue sensitivity after hadrontherapy
Suetens, Annelies; Moreels, Marjan; Quintens, Roel; 
d’Agostino, Emiliano; Tabury, Kevin; Baatout, Sarah
Laboratory of Radiobiology, Belgian Nuclear Research centre, ScKceN, Mol, BeLGIUM
Hadrontherapy is a type of cancer radiation therapy, which uses beams of 
charged particles such as carbon ions. Compared to conventional X-ray therapy, 
the main advantage of hadrontherapy is the ability to more precisely localize 
the radiation dosage combined with an increased biological effectiveness. This 
high ballistic accuracy allows depositing the maximal dose to the tumor, while 
damage to the surrounding healthy tissue can be limited. First results obtained 
from prostate cancer patients treated with carbon ion therapy, show good 
local tumor control and survival rates. However, despite the superior precise 
dose localization of hadrontherapy, the surrounding healthy tissues (e.g. large 
intestinal tract, bladder, urethra) are inevitably co-irradiated. So far, the impact 
of hadrontherapy on radiation toxicity of healthy tissues (e.g. gastro-intestinal 
tract) which surround the target tumor is still not clear and many aspects still 
need to be investigated.
The main objective of this project is to study the biological response of 
normal colon cells (NCM460) after in vitro exposure to carbon ions or X-ray beams 
at various low to high doses. Potential quantitative and qualitative differences 
between carbon ion irradiation and conventional X-rays are currently being 
studied. In particular, the topics of interest in this study are the investigation of 
acute cellular responses such as cell cycle progression and apoptosis at various 
time points following the irradiation. In a later stage, these results will be 
correlated with data obtained by high-throughput screening of gene expression 
and secreted proteins (cytokines) linked to inflammation.
Obtained results will bring more insight into cellular response of 
non-cancerous cells to different types of radiation and the underlying molecular 
pathways that are involved. This research is essential to obtain a better 
understanding of the treatment effect on the healthy surrounding tissue.
Acknowledgements: This work is partly supported by the Federal Public Service 
in the context of the feasibility study ‘Application of hadrontherapy in Belgium’, 
which is part of action 30 of the Belgian cancer plan.
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Micronucleus-centromere test in lymphocytes 
from currently active uranium miners and radon 
spa personnel in the Czech Republic
Zölzer, Friedo1; Hon, Zdenek1,2; Freitinger Skalická, Zuzana1;  
Havránková, Renata1; Navrátil, Leoš1,2; Rosina, Jozef1,2; Škopek, Jirí1
1 University of South Bohemia in ceské Budejovice, Faculty of Health and Social Studies, Department of Radiology and 
Toxicology, cZecH RePUBLIc; 2 czech Technical University in Prague, Faculty of Biomedical engineering, Department of 
Humanities and Medicine, Kladno, cZecH RePUBLIc
The micronucleus-centromere test is one of the most sensitive methods of 
biodosimetry available. Here we tested its applicability in currently active 
uranium miners and radon spa personnel. The frequency of micronucleus-
containing cells and the percentage of centromere-free micronuclei (micronuclei 
containing only acentric fragments) was determined in peripheral blood 
lymphocytes of 72 individuals working in the Rožna mine, 42 individuals working 
at the Jáchymov spa and 42 control individuals. There was a significant increase 
in the frequency of micronucleus-containing cells as well as the percentage of 
centromere-free micronuclei in the lymphocytes of both uranium miners and 
radon spa personnel when compared with the control group. For the miners, both 
parameters correlated with the effective dose received during work, which was in 
the order of several tens of mSv. No individual dosimetry data were available for 
the spa personnel; a comparison with the results from uranium miners suggested 
that accumulated effective doses were very similar in both cases. We conclude 
that the micronucleus-centromere test is able to pick up relatively small effective 
doses which are due preferentially to the inhalation of radionuclides.
ˇ
ˇ
ˇ ˇ
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Mouse lens epithelial cells and lymphocytes 
exhibit similar sensitivity to γ-irradiation
Graw, Jochen1; Bannik, Kristina1*; Faus-Kessler, Theresa1;  
Gomolka, Maria2; Hornhardt, Sabine2; Dalke, Claudia3;  
Rosemann, Michael3; Atkinson, Michael3; Kulka, Ulrike2; Rössler, Ute2
1 Helmholtz center Munich, Institute of Developmental Genetics, Neuherberg, GeRMaNY; 2 Federal Office for Radiation 
Protection, Department of Radiation Protection and Health (SG1.1), Oberschleissheim, GeRMaNY; 3 Helmholtz center 
Munich, Institute of Radiation Biology, Neuherberg, GeRMaNY
*current address: Department of Radiotherapy, University Hospital, essen, GeRMaNY
In this pilot study we compared for the first time the radiation sensitivity of mouse 
lens epithelial cells (LECs) and mouse lymphocytes from two genetically different 
mouse strains, C57BL / 6J and JF1, respectively. We have chosen C57BL / 6J mice 
as a widely used reference strain and JF1 because of its different susceptibility 
for radiation sensitivity (Dalke et al., 2012).
LECs and mouse lymphocytes were freshly prepared. Cells were irradiated 
with 0.25 – 2 Gy from a 137Cs-source at 2 Gy/min. DNA damage and repair were 
evaluated by alkaline comet-assay and γH2AX foci assay.
LECs and lymphocytes showed a dose-dependent increase of DNA-damage 
as indicated by all parameters derived from the comet assay. In particular, 
analyzing parameter “percentage of DNA in the comet tail”, both cell types exhibit 
similar radiation sensitivity.
Additionally, the number of DNA double strand breaks in LECs and 
lymphocytes from C57BL / 6J and JF1 mice were compared by γH2AX analysis: After 
1 Gy irradiation repair of DNA damage proceeded faster in LECs. A significantly 
higher residual damage was observed in lymphocytes after 24 h. No significant 
difference was detected between the two mouse strains with respect to DNA repair.
Our results demonstrate that on the DNA level, lens epithelial cells and 
lymphocytes exhibit a similar sensitivity to ionizing radiation. Moreover, the 
observed difference in DNA repair between the two cell types in both strains as 
indicated by the data of the γH2AX assay need further experiments to identify 
the underlying molecular mechanisms.
References
Dalke J, Hölzlwimmer G, Calzada-Wack J, Quintanilla-Martinez L, Atkinson 
MJ, Rosemann M. Differences in the susceptibility to Iodine131-induced 
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Cytogenetic endpoints in endothelial cells (HUVEC) 
exposed to protracted LDR irradiation 
Kiuru, Anne1; Lindholm, Carita1; Koivistoinen, Armi1; Haghdoost, Siamak2;  
Deperas, Marta2; Yentrapalli, Ramesh2; Launonen, Virpi1; Harms-Ringdahl, Mats2
1 STUK – Radiation and Nuclear Safety authority, Helsinki, FINLaND;  
2 centre for Radiation Protection Research, GMT, University of Stockholm, Stockholm, SWeDeN
Endothelial cells cultured under protracted irradiation were assessed with 
cytogenetic endpoints including chromosomal aberration (CA) and telomere 
length analyses. The endothelial HUVEC cell line was irradiated at Stockholm 
University at low dose rates (1.4, 2.4, and 4.1 mG / h). In order to follow the 
cytogenetic damage induced during the protracted exposure, cell harvests at time 
points 1, 3, 6, and 10 weeks, were performed. Another experiment was performed 
where cells grown for 1, 3, 6, and 10 weeks under irradiation were placed for 
another 10 days in non-exposure conditions before harvest.
The HUVEC cell line turned out to be very challenging for cytogenetic 
assays due to the variable, mainly tetraploid, chromosome number. In all, 100 
cells were analysed for CA per data point. CA of both chromosome and chromatid 
types were observed. In general, cells harvested directly after irradiation, 
demonstrated an increase in aberration frequencies with longer exposure times/
higher protracted dose. No such trend was observed in cells cultured without 
irradiation during an extra 10 days. In situ hybridization (FISH) with telomere 
probe was performed to assess telomere length at the corresponding culture times 
and dose rates. Data from both telomere length assessment and CA scoring will 
be presented. The work performed is part of  Task 7.3 “Feasibility study towards 
a systems biology approach of radiation response of the endothelium” in the 
DoReMi project.
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Systematic review and meta-analysis of circulatory 
disease from exposure to low-level ionizing radiation 
and estimated potential population mortality risks
Little, Mark1; Azizova, Tamara2; Bazyka, Dimitry3; Bouffler, Simon4; Cardis, Elisabeth5;  
Chekin, Sergey6; Chumak, Vadim3; Cucinotta, Francis7; de Vathaire, Florent8; Hall, Per9;  
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Kreuzer, Michaela11; Laurent, Olivier12; Ozasa, Kotaro13; Schneider, Thierry14; Tapio, Soile15;  
Taylor, Andrew16; Tzoulaki, Ioanna17; Vandoolaeghe, Wendy17; Wakeford, Richard18;  
Zablotska, Lydia19; Zhang, Wei4; Lipshultz, Steven20
1 Radiation epidemiology Branch, National cancer Institute, Rockville, USa; 2 Southern Urals Biophysics Institute, 
Ozyorsk, RUSSIa; 3 Research center for Radiation Medicine, Kyiv, UKRaINe; 4 Health Protection agency, centre for 
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Group, INSeRM Unité U1018, Institut Gustave Roussy, Villejuif, FRaNce; 9 Department of Medical epidemiology 
and Biostatistics, Karolinska Institute, Stockholm, SWeDeN; 10 Department of Radiotherapy and Radiation Oncology, 
University of Rostock, Rostock, GeRMaNY; 11 Federal Office for Radiation Protection, Department of Radiation 
Protection and Health, Oberschleissheim, GeRMaNY; 12 Laboratoire d’epidémiologie, Institut de Radioprotection 
et de Sûreté Nucleaire, Fontenay-aux-Roses, FRaNce; 13 Department of epidemiology, Radiation effects Research 
Foundation, Hiroshima city, JaPaN; 14 cePN (Nuclear evaluation Protection center), Fontenay-aux-Roses, FRaNce; 
15 Helmholtz Zentrum München, German Research centre for environmental Health, Institute of Radiation Biology 
(ISB), Radiation Proteomics, Oberschleissheim, GeRMaNY; 16 UcL Institute of cardiovascular Sciences & Great 
Ormond Street Hospital for children, London, UK; 17 Department of epidemiology and Biostatistics, Imperial college 
Faculty of Medicine, London, UK; 18 Dalton Nuclear Institute, University of Manchester, Manchester, UK; 19 Department 
of epidemiology and Biostatistics, University of california San Francisco School of Medicine, San Francisco, USa; 
20 Department of Pediatrics, Leonard M. Miller School of Medicine, University of Miami, USa
Background: Although high doses of ionizing radiation have long been linked 
to circulatory disease, evidence for an association at lower exposures remains 
controversial. There is emerging evidence of risks at low doses and dose rates.
Methods: We performed a systematic review and meta-analysis to summa-
rize information on circulatory disease risks associated with moderate- and low-
level whole-body ionizing radiation exposures (Little et al., 2012). We conducted 
Medline / ISI Thompson searches of peer-reviewed papers published since 1990 
using the terms “radiation” +“heart”+ “disease” or “radiation” +“stroke” or “radia-
tion” +“circulatory” +“disease”. Radiation exposures had to be whole-body, with 
cumulative mean dose < 0.5 Sv, or at low dose rate. We estimated low dose popu-
lation risks of circulatory disease using excess relative risk estimates from this 
meta-analysis and current mortality rates for nine major developed countries. 
results: Estimated excess population risks for all circulatory diseases 
combined ranged from 2.5% per Sv (95% CI 0.8 to 4.2) for France to 8.5% per Sv 
(95% CI 4.0 to 13.2) for Russia (Little et al., 2012).
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Conclusions: Our review supports an association between circulatory 
disease mortality and low and moderate doses of ionizing radiation. Our analysis 
was limited by heterogeneity among studies (particularly for non-cardiac 
endpoints), the possibility of uncontrolled confounding in some occupational 
groups by lifestyle factors, and higher dose groups (> 0.5 Sv) generally driving 
the observed trends. Our findings suggest that overall radiation-related mortality 
is about twice that currently estimated for cancer (4.2% – 5.6% per Sv for these 
populations) (Little et al., 2012).
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Low dose effects on brain
Lumniczky, Katalin; Balogh, Andrea; Bogdándi, Noémi; 
Benedek, Anett; Persa, Eszter; Sáfrány, Géza
F. Joliot-curie National Research Institute for Radiobiology and Radiohygiene, anna 5, Budapest, 1221, HUNGaRY
Background: Low-dose irradiation might increase the incidence of ischemic 
cardiovascular diseases, however, much less attention is paid to low-dose radiation 
effects on the microvasculature of the brain and its microenvironment. We have 
studied low-dose irradiation induced mitochondrial damage in the whole brain 
and in the endothelial cells of the brain microvasculature. 
Methods: Since developing brain might be more susceptible to low-dose 
induced long-term alterations, we investigated 10-day old C57BL / 6 mice. Animals 
were irradiated on their head with single doses of 0.1 or 2 Gy X-rays. 1, 3, 7 days 
and 1 month after irradiation mice were sacrificed, and single cell suspensions 
of the various brain regions (cortex, cerebellum, hipotalamus) made. Half of the 
brains were processed for biochemical measurements of enzyme activities of the 
respiratory chain in the mitochondrial membrane. The other halves were stained 
with Rhodamine 123 to evaluate alterations in the mitochondrial membrane 
potential, with Mitosox Red to determine the level of superoxide anions in the 
mitochondrial membrane. By costaining the cells with the endothelial specific 
marker CD31, we studied mitochondrial damage within the endothelial cells 
as well. 
results: A reduction of cytochrome C oxidase activity was detected after 
irradiation with 2 Gy, while 0.1 Gy had only moderate effect compared to control. 
The other enzymes in the respiratory chain are under investigation. A moderate, 
dose-dependent increase was seen in the level of mitochondrial superoxide as 
well as in the level of mitochondrial membrane potential damage 3 days after 
irradiation, which normalized after 1 week. Mitochondrial damage in the CD31 
cells seems to be consistently higher than that found in the unfractionated brain 
cell suspension. 
Conclusions: Low-dose local irradiation induces moderate but detectable 
mitochondrial alterations both in the brain and in the endothelial cells of the 
microvascular compartment of the brain.
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Towards a better knowledge of cardiovascular doses 
following radiotherapy using hybrid computational phantoms
Moignier, Alexandra1; Broggio, David1; Derreumaux, Sylvie1;  
Chea, Michel2; Boisserie, Gilbert2; Girinsky, Théodore3; Paul, Jean-François4;  
Aubert, Bernard1; Franck, Didier1; Mazeron, Jean-Jacques2
1 Institut de Radioprotection et de Sûreté Nucléaire (IRSN), FRaNce; 2 Groupe hospitalier de la Pitié-Salpêtrière, 
FRaNce; 3 Institut Gustave Roussy, FRaNce; 4 centre chirurgical Marie-Lannelongue, FRaNce
A general awareness of the cardiovascular diseases following radiotherapy has 
emerged for few years. The implied biological mechanisms are only partially 
understood and a better knowledge of the cardiovascular doses is certainly 
needed to better establish a dose-effect relationship. To date, retrospective studies 
perform dose reconstruction with a representative patient or a mathematical 
phantom, which introduce dose error due to the non-personalization of the 
considered anatomy. It is all the more problematic that the heart can be located 
in a high dose gradient during breast or Hodgkin lymphoma radiotherapies. Here, 
hybrid computational phantoms are used in order to reduce dose uncertainties 
due to anatomical approximations (Moignier et al., 2012). 
In the case of left breast radiotherapy, thoracic models adapted to the 
patient anatomy and including a generic detailed heart model with coronaries 
have been generated. When the CT scan of the patient is available, the insertion 
of a detailed heart model compensate for the absence of coronaries on the imaging 
used for treatment planning. For retrospective studies, when only orthogonal 
chest radiographies are available, the thoracic model is deformed to fit the 
orthogonal views, ensuring a better beam positioning than with a representative 
patient and hence a better dose assessment.
Since most of the cardiovascular diseases are due to coronary lesions it is 
all the more important to specify coronary doses. For this purpose, rather than 
using a generic heart model it is possible to use patient’s coroscans showing 
the detailed coronary pattern. Dose reconstructions have been performed for 20 
patients treated for Hodgkin lymphoma between 1996 and 2010. Inclusion of 
the heart anatomy in the patient 3D model enables to establish a dose mapping 
at the coronary level.
References
Moignier A et al. Potential of hybrid computational phantoms for retrospective heart 
dosimetry after breast radiation therapy: A feasibility study. Int J Radiat Oncol 
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Two-dimensional difference gel electrophoresis 
analysis of short-term response of human endothelial 
cell line EA.hy926 to gamma radiation
Nylund, Reetta; Lemola, Elina; Eklund, Elina; Hakanen, Arvi; Leszczynski, Dariusz
STUK – Radiation and Nuclear Safety authority, Helsinki, FINLaND
Epidemiological studies indicate that moderate and low radiation doses to the 
heart area may result in an increase in cardiovascular mortality. This has been 
suggested to occur for instance among breast cancer patients, who are exposed 
therapeutically. However, it is not known how the cardiovascular damage is 
created by the low doses of ionizing radiation. It has been suggested that heart 
endothelium could be one of the targets for the ionizing radiation-induced heart 
injury. The aim of this study was to examine the short-term proteome level 
response in endothelial cells to low and moderate doses of γ-radiation.
Human endothelial cell line EA.hy926 was used as in vitro model in this 
study. Cells were exposed to γ-radiation at doses of 200 mGy and 1 Gy using Co-60 
source. Cells were harvested in three time points (10 min, 30 min, and 4 hours) 
after the exposure. Protein expression changes were examined in total cell lysates 
using two-dimensional difference gel electrophoresis (2DE-DIGE). Differences 
in protein expression were examined using statistical testing with correction 
for multiple comparisons as well as based on fold ratios between exposed and 
control samples. No significant changes were found in protein expression in any 
of the examined experimental conditions. However, western blotting showed 
that 53BP1 protein was phosphorylated in dose- and time-dependent manner 
in response to γ-radiation.
Our results suggest that the exposure of EA.hy926 cells to γ-radiation doses 
of 200 mGy and 1 Gy does not cause acute changes in the proteome. Detected 
changes in the phosphorylation of 53BP1 protein indicate that the exposure 
caused DNA damage in cells and thus, cells responded to irradiation. Further 
examination of cellular proteome, using more sensitive techniques (MS / MS), 
is warranted and might reveal changes, which are not detected by 2DE-DIGE.
Manuscript of this study has been submitted for publication.
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Identification of novel p53 target genes 
in the developing mouse brain
Quintens, Roel; Samari, Nada; Meulepas, Christelle; Pani, Giuseppe;  
Janssen, Ann; Michaux, Arlette; Neefs, Mieke; Baatout, Sarah; Benotmane, Rafi
Radiobiology Unit, Belgian Nuclear Research centre, BeLGIUM
Epidemiological data from atomic bomb survivors have shown that in utero 
exposure to low radiation doses especially between weeks 8 – 5 of pregnancy led 
to an increased incidence of severe mental retardation among these subjects later 
in life. We found that this can be mimicked in mice by irradiating pregnant mice 
at day 12 of gestation (E12) with 1 Gy of X-rays. To identify possible molecular 
mechanisms which are responsible for this effect, we analysed gene expression in 
the fetal brains after 2 h following irradiation. Results showed a dose-dependent 
increase in genes involved in cell cycle arrest, DNA repair and apoptosis, which 
are known to be mediated by the tumour suppressor p53. However, a number of 
upregulated genes were so far not known to be regulated by p53.
Therefore, we analysed several of these radiation-induced genes for 
putative p53 binding sites using a matrix scanning algorithm. For all of the 
tested genes, we identified at least one predicted p53 binding site (p <10-4) within 
the investigated genomic sequences. Chromatin immunoprecipitation with an 
antibody against phosphorylated p53 showed that these genes are indeed in vivo 
targets of p53 in response to X-irrradiation of the E12 mouse brain. To further 
confirm the involvement of p53 in the transcriptional activation of these genes 
upon irradiation, we analyzed mRNA expression in irradiated primary cultures 
of cortical neurons from wild-type (p53+/+) versus p53-deficient (p53-/-) mice. 
Expression of most of these genes was significantly induced in cells from p53+/+ 
mice, whereas no difference in expression could be observed in cells from p53-/- 
mice. Thus, we have identified new p53 target genes in the fetal mouse brain 
that are transcriptionally activated after exposure to ionizing radiation and we 
therefore extend the p53 transcriptional network.
Acknowledgements: This work is supported by the EU FP7 projects CEREBRAD 
and DoReMi.
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The endothelium response to low dose ionizing radiation
Rombouts, Charlotte1,2; Aerts, An1; Beck, Michael1,2; Tabury, Kevin1;  
De Vos, Winnok2; Benotmane, Rafi1; Van Oostveldt, Patrick2; Baatout, Sarah1,2
1 Radiobiology Unit, ScKceN, Mol, BeLGIUM 2 Department of Molecular Biotechnology, Ghent University, Ghent, BeLGIUM
High radiation doses (> 5 Gy) increase the risk of cardiovascular diseases (CVD). 
In recent years, epidemiological data support the fact that lower radiation 
doses increase the risk of CVD as well and this after much longer intervals 
than previously expected (cfr. Atomic bomb survivors). However for radiation 
doses below 0.5 Gy, these epidemiological findings are unclear and a better 
understanding of the underlying biological and molecular mechanisms is needed. 
The endothelium is believed to be a critical target in the development of radiation-
related CVD because of its pivotal role in normal vascular functioning.
In this work, we used the immortalized endothelial cell line EA.hy926 
and primary Human Umbilical Vein Endothelial cell (HUVEC) as models, to 
characterize the endothelial response to low (< 0.5 Gy) and medium (0.5 – 5 Gy) 
acute doses of X-rays (250 keV, 15 mA, 1 mm Cu, 0.25 ± 0.01 Gy/ h). In particular, 
we analysed the influence of radiation on DNA damage, cell cycle changes, and 
associated apoptosis. DNA damage was induced by doses as low as 0.05 Gy as 
observed by a significant increase in γH2AX-foci number 30 min after exposure 
in both cell lines. Foci number returned to baseline levels 24 h after exposure, 
indicating DNA repair. Changes in cell cycle 24 h after exposure, as seen by a G2 
arrest, were limited to 5 Gy in both cell lines. A significant increase in apoptotic 
cells was observed to doses as low as 0.1 Gy for EA.hy926 cells and as low as 0.5 
Gy for HUVECs 48 h after exposure.
Based on our results, it is concluded that DNA damage and apoptosis 
following radiation exposure is more pronounced in EA.hy926 cells compared 
to HUVECs. This indicates a larger radiation sensitivity of EA.hy926 cells for 
these investigated endpoints. In future research we will include gene expression 
profiling to get a better understanding of the underlying signalling pathways. In 
the context of radiation-related CVD assessment of ROS production, mitochondrial 
DNA damage and inflammatory response (adhesion of leukocytes and cell-cell 
integrity) will be performed as well. 
Acknowledgements: This project is supported by the EU FP7 DoReMi network of 
excellence (grant agreement: 249689).
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Maturating neurons exhibits a delay in 
neurite outgrowth upon exposure to low and 
moderate doses of ionising radiation
Samari, Nada; Pani, Giuseppe; Quintens, Roel; Michaux, Arlette; 
Janssen, Ann; Baatout, Sarah; Benotmane, M. Abderrafi
Radiobiology Unit, Belgian Nuclear Research centre, Mol, BeLGIUM
In human, the period of fetal development (8 to 15 weeks of gestation) is highly 
sensitive to ionizing radiation. Epidemiological data have reported cases of mental 
retardation and decrease in school performance within victims of Hiroshima and 
Nagazaki A-bombing, irradiated in utero during the fetal period. Several studies 
have been performed to assess the risk of ionizing radiation on fetal and children 
health but a lot is still to be done in order to understand the radiation-induced 
brain damage, especially following exposure to low doses of radiation.
In this study, we aimed at observing morphological changes in neurons 
following exposure to low and moderate doses of X-rays during their early 
maturation period, followed by gene expression analysis. For this purpose we 
have used nearly pure primary cultures of neurons extracted from E17 mouse 
fetus in order to reveal specific response of neurons to ionizing radiation. This 
study revealed a reduction in neurite length, neurite number and branching 
points number following exposure to doses of 0.1, 0.2 and 0.5 Gy of X-rays. 
A 3 days follow-up of these cultures after irradiation showed a resuming 
of neurite outgrowth, which remained however insuficient to overcome the 
inhibition induced by radiation. Microarray analysis using GSEA indicated a 
significant downregulation of pathways involved in cytoskeleton remodeling 
and synaptogenesis. This study showed that a dose as low as 0.1 Gy was enough 
to induce neurite outgrowth inhibition which may ultimatly lead to a defect in 
neuronal network connection and to improper neuronal communication. 
Acknowledgements: This work was supported by both EU projects; the DoReMi 
Network of Excellence (GA 249689) and the CEREBRAD (GA 295552).
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Dose – responses from multi-model inference for  
the non-cancer disease mortality of atomic bomb survivors
Schöllnberger, Helmut1; Kaiser, Jan-Christian1; Walsh, Linda2; 
Cullings, Harry3; Shimizu, Yukiko4; Jacob, Peter1
1 Helmholtz Zentrum München, Department of Radiation Sciences, GeRMaNY; 2 BfS-Federal Office for Radiation 
Protection, GeRMaNY; 3 Radiation effects Research Foundation, Statistics Department, JaPaN; 4 Radiation effects 
Research Foundation, Department of epidemiology, JaPaN
The non-cancer mortality data for cerebrovascular disease (CVD) and 
cardiovascular diseases without CVD from Report 13 on the atomic bomb survivors 
published by the Radiation Effects Research Foundation were analysed to 
investigate the dose –response for the influence of radiation on these detrimental 
health effects. Various parametric and categorical models (such as linear-no-
threshold (LNT) and a number of threshold and step models) were analysed 
with a statistical selection protocol that rated the model description of the data. 
Instead of applying the usual approach of identifying one preferred model for 
each data set, a set of plausible models was applied, and a sub-set of non-nested 
models was identified that all fitted the data about equally well. Subsequently, 
this sub-set of non-nested models was used to perform multi-model inference 
(MMI), an innovative method of mathematically combining different models 
to allow risk estimates to be based on several plausible dose –response models 
rather than just relying on a single model of choice. For CVD, MMI yielded a 
weak dose –response (with a risk estimate of about one-third of the LNT model) 
below a step at 0.6 Gy. Above the step at 0.6 Gy the dose –response continues in 
a linear fashion with statistically significant risk values. For mortalities related 
to cardiovascular diseases without CVD, an LNT-type dose –response was found 
up to a threshold dose at 2.2 Gy. At this dose a small step occurs in the dose –
response for MMI. Above that step the dose –response continues in an essentially 
linear fashion with statistically significant risk values. For both endpoints the 
90% confidence intervals related to the MMI include the value of zero below the 
threshold doses (Schöllnberger et al., 2012). The authors will also present results 
from their analyses of the latest non-cancer mortality data related to the atomic 
bomb survivors (Shimizu et al., 2010).
References
Schöllnberger H, Kaiser JC, Walsh L, Jacob P. Dose-responses from multi-model 
inference for the non-cancer disease mortality of atomic bomb survivors. 
Radiation and Environmental Biophysics 2012; 51 (2): 165 – 178.
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Shimizu Y, Kodama K, Nishi N et al. Radiation exposure and circulatory disease 
risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950 – 2003. 
Brit Med J 2010; 340: b5349.
89
STUK-A254Posters 2B: Non-cancer effects
Quantitative proteomic analysis of endothelial cells 
isolated from locally irradiated mouse hearts
Tapio, Soile1; Azimzadeh, Omid1; Sievert, Wolfgang2; Yentrapalli, Ramesh1,3;  
Sarioglu, Hakan4; Ueffing, Marius4; Barjaktarovic, Zarko1;  
Multhoff, Gabriele2; Atkinson, Michael J.1, 2
1 Helmholtz Zentrum München, German Research center for environmental Health, Institute of Radiation Biology, 
Neuherberg, GeRMaNY; 2 Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität 
München, Munich, GeRMaNY; 3 centre for Radiation Protection Research, Department of Genetics, Microbiology and 
Toxicology, Stockholm University, Stockholm, SWeDeN; 4 Helmholtz Zentrum München – German Research center for 
environmental Health, Research Unit Protein Science, Neuherberg, GeRMaNY
Radiation exposure is associated with a significantly increased risk of cardiac 
morbidity and mortality after a latency period of several decades. One of the main 
targets of radiation is the endothelial cell (EC) layer in the cardiac micro- and 
macrovasculature. 8-week old C57Bl /6 mice were locally irradiated on the heart 
using X-ray doses of 8 and 16 Gy and sacrificed after 16 weeks. After mechanic 
and enzymatic digestion of the heart tissue viable primary ECs were isolated 
using streptavidin-CD31 coated microbeads and tested for purity by FACS 
analysis. In order to quantify radiation-induced proteome alterations, the ECs 
were labelled with duplex Isotope Coded Protein Label (ICPL) methodology using 
three biological replicates isolated from control vs. exposed mice. To investigate 
the cross talk between the endothelium and cardiac tissue after radiation damage, 
we compared the whole heart lysates after similar exposures again using the 
ICPL labelling. All samples were analysed by ESI LC-MS / MS and Proteome 
Discoverer software. The response of the endothelium seemed to be distinct from 
that of the cardiac tissue. Ionising radiation induced significant alterations in 
the actin cytoskeleton and leukocyte extravasation signalling of the endothelium 
whereas in the cardiac tissue lipid metabolism and oxidative phosphorylation 
were the most affected pathways. Marked changes in the peroxisome proliferator-
activated receptor (PPAR) regulation of fatty acid metabolism were found in both 
proteomes. The proteomics data were further analysed by bioinformatics tools 
and validated by immunoblotting. 
This study will facilitate the identification of biomarkers associated with 
adverse cardiac effects of ionising radiation and the development of individualised 
radiotherapy.
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Low/intermediate dose ionising radiation induces 
an anti-inflammatory phenotype of activated 
peritoneal macrophages of BALB/c mice
Wunderlich, R.1; Frischholz, B.1; Roedel, F.2; Fietkau, R.1; Frey, B.1; Gaipl, U.S.1
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Low and intermediate dose ionising radiation (LD-X-ray) is applied in treatment of 
painful and degenerative inflammatory diseases. The resulting anti-inflammatory 
effects are based on the one hand on alterations of chemokine profiles and 
adhesion molecules on immune cells. On the other hand, despite lowering 
the amount of inflammatory immune cells, a LD-X-ray induced change of the 
phenotype of activated immune cells is also assumed. Key players in regulation 
of inflammation are macrophages that are cells of the innate immunity. They 
secrete inflammatory cytokines such as Interleukin (IL)-1β or tumour necrosis 
factor (TNF)-α upon stimulation. In terms of medical application of LD-X-ray, 
but also of radiation protection issues, it is reasonable to expand our knowledge 
on how key immune cells involved in inflammation get modulated by LD-X-ray. 
Of special interest is how varying radiosensitivities due to the different genetic 
backgrounds influence this modulation.
We have previously shown that 0.5 or 0.7 Gy of LD-X-ray significantly 
reduces the amount of secreted IL-1β of human THP-1 macrophages that have 
been activated with lipopolysaccharide (LPS) and co-activated with monosodium 
urate crystals (MSU). Using now an ex-vivo model of peritoneal mouse 
macrophages obtained from mouse strains differing in their basal radiosensitivity, 
we also observed a significantly reduced secretion of IL-1β and a slight, but not 
significant, reduced secretion of  TNF-α of activated (LPS plus MSU) macrophages 
of BALB /c mice after LD-X-ray treatment with 0.5 or 0.7 Gy. In contrast, the 
secretion of IL-1β and TNF-α of activated peritoneal macrophages from the less 
radiosensitive C57BL / 6 mice was not influenced by LD-X-rays.
We then tested whether the secretion of cytokines by peritoneal macrophages 
of BALB /c mice that had only been activated with one stimulus (LPS before 
LD-X-ray) is also modulated by exposure to ionising irradiation. One day after 
irradiation, the IL-1β secretion was decreased after irradiation with 0.5, 0.7, 1.0 
and 2.0 Gy. Of note is that also 0.01 Gy of X-ray led to decreased secretion of 
IL-1β while 0.05, 0.1, and 0.3 did not change the amount. Further, the amount 
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of secreted TNFα was slightly reduced by single doses of X-ray of 0.5, 0.7, 1.0 
and even 2.0 Gy.
We conclude that only the inflammatory phenotype of more radiosensitive 
macrophages is reduced by LD-X-ray and that ex vivo and in vivo models with 
primary cells should be increasingly applied in the future to examine how the 
immune system is modulated by LD-X-ray. Future research will also reveal which 
inflammatory pathways such as the NFκB p65 and p-p38 MAPK get modulated 
by LD-X-rays.
Acknowledgements: This work is supported by the European Commissions 
(DoReMi, European Network of Excellence, contract number 249689).
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How can the Eurados Network on Retrospective 
Dosimetry contribute to research in low doses?
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A Eurados (European Radiation Dosimetry Group) network of biological and 
physical dosimetrists was created (as Working Group 10) in 2008 with the aim 
to harmonize existing methods of retrospective dosimetry, to implement and 
validate new methods and to disseminate the scientific knowledge.
As a first action, WG10 has reviewed properties and drawbacks of retro-
spective dosimetry methods in low dose epidemiological studies and in emer-
gency situations (Ainsbury et al., 2011) concluding with the identification of 
two needs: 1) to establish the usefulness and limitations of biological dosimetry 
in internal and mixed internal /external exposures and 2) to harmonize uncer-
tainty analysis among the various methods. Two task groups have been created 
to explore these topics.
Moreover, within WG10, an inter-comparison to validate the EPR / OSL 
retrospective dosimetry method with portable devices is in progress and the 
Eurados School on Retrospective Dosimetry will be organized in Neuherberg, 
Germany, in October 2012, to train young scientists in different physical and 
biological assays for retrospective dose assessment.
References 
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Cellular dosimetry of Sr-90 using Monte Carlo code MCNPX
Hocine, Nora1; Farlay, Delphine2; Bertho, Jean Marc1; Desbrée, Aurélie1; 
Franck, Didier1; Agarande, Michelle1; Boivin, Georges2
1 Institut de Radioprotection et de Sûreté Nucléaire, FRaNce;  
2 INSeRM UMR 1033, Université de Lyon, faculté de médecine (domaine Laennec), FRaNce
The aim of our study is to provide data that increases knowledge about possible 
health effects of exposure to Sr-90 contaminant in drinking water. The cellular 
localization in the mouse bone model plays an important complementary role 
with computational dosimetry in these investigations. This early research work 
is focused on using MCNPX and its validation at cellular level using three-
dimensional voxelised geometry. S-values (absorbed dose per unit cumulated 
activity) calculations using Monte Carlo (MC) simulations are carried out. 
Cytoplasm (Cy), nucleus (N) and Sr-90 radiation source were simulated with MC 
code MCNPX. In the first step of this study, cells are assumed to be spherical 
with the radii of the cell and cell nucleus ranging from 2 to 10 µm. Different 
source to target combinations including nucleus to nucleus (N←N), cytoplasm 
to nucleus (N←Cy) are considered. The S-values (in Gy/ Bq.s) were calculated 
for cell nucleus and cytoplasmic distribution of radioactivity. 
A comparison of MC results with the MIRD values presented by Goddu et 
al., for the N←Cy configuration shows that deviations are less than 6% (5.5%). 
We generally find the largest deviations with MIRD for geometries where the 
target is at some distance from the source and, therefore, the results depend 
more strongly upon the penetration ability of electrons.
References
Goddu SM, Howell RG, Bouchet LG, Bolch WE, Rao DV. MIRD Cellular S Values. 
1997 (Reston, VA: Society of Nuclear Medicine).
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Transcriptional dose-responses of radiation biomarkers 
in human and mouse blood samples ex vivo
Manning, Grainne; Kabacik, Sylwia; Finnon, Paul; Bouffler, Simon; Badie, Christophe
Biological effects Department, centre for Radiation, chemical and environmental Hazards, Health Protection agency, 
chilton, Didcot, Oxfordshire OX110RQ, UK
Modifications of gene expression following ionising radiation (IR) exposure of 
cells in vitro and in vivo have been well documented in the last few years. Recent 
studies have identified radiation responsive genes in human blood which can be 
potentially used for biological dosimetry. However, little is known about the dose-
responses, especially at low doses. We have developed a multiplex quantitative 
reverse transcription polymerase chain reaction (MQRT-PCR) assay to accurately 
study modifications of gene expression following IR in human blood samples 
exposed ex vivo. Here we looked at dose responses in ex vivo irradiated human 
blood over a range of doses from 5 mGy up to 100 mGy and at two different 
time-points of 2 hr and 24 hr using a panel of 13 biomarkers of exposure (BBC3, 
CDKN1A, CCNG1, DDB2, FAS, FDXR, GADD45, MDM2, MYC, PCNA, PHPT1, 
SESN1, TIGAR). Linear responses were observed at low doses (5 mGy – 100 mGy) 
with an R2 value of 0.939 for FDXR at 2 hrs. A linear response was also observed 
at low doses at 24 hrs with R2 values reaching 0.984 for DDB2 and 0.973 for 
FDXR. A dose estimation curve was developed from the low dose response of two 
donors and a further 8 donors were irradiated with a dose of  100 mGy at 24 hrs to 
assess individual response to low dose exposure. Using linear regression analysis, 
lower and upper 95% confidence intervals of  47 mGy and 128 mGy were obtained 
for CCNG1. Mouse blood (C57BL / 6) irradiated at low doses ex vivo with a time-
point of 2 hrs also produced a linear response. R2 values of 0.94 and 0.91 were 
obtained for the genes Bbc3 and Cdkn1a. These findings illustrate the linear 
response of specific genes in the low dose region and identify genes that fulfil 
some of the requirements of a good exposure biomarker, such as sensitivity and 
simple proportionality with dose.
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Toxicokinetic of uranium nanoparticles 
after inhalation in rats
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The remediation and decommissioning of nuclear facilities lead to the use of 
processes that can generate nanoparticules (< 100 nm) containing uranium. The 
risk of accidental inhalation of nanoparticles by operators implementing such 
processes must be taken into account. For relevant dose calculation, it is strongly 
recommended in ICRP publication 66 to characterize in vivo or in vitro specific 
absorption rate for the aerosol of interest. Concerning uranium, absorption 
rate of inhaled ultrafine particles have never been assessed experimentally. To 
address this question, the present study considered, in vivo in rat, respiratory 
tract deposition, incorporation and biodistribution of uranium nanoparticles 
after inhalation. Rats were exposed, in a “nose only system”, during 1 hour to 
an aerosol containing 107 particles of uranium / cm3. The median diameter in 
number of these particles was 40 nm (δg = 2 nm). The quantities of uranium 
deposited in respiratory tract compartments and in target organs of uranium 
toxicity (skeleton and kidneys) were determined by ICP-MS 10 minutes, 4 hours 
and 24 hours after the end of inhalation. The results showed that 27% of the 
mass of inhaled uranium nanoparticles were deposited in the airways. 97% of the 
deposited mass of uranium were located in the deep lung. At the end of inhalation, 
5.7% of the uranium deposited in the airways were transferred into the blood. 
24 hours after inhalation, 3.1%, 4.6% and 77% of the incorporated uranium were 
located in skeleton, kidneys and airways, respectively. The rapid phase of lung 
clearance of UO2 nanoparticles was similar to industrial UO4 microparticles 
(Type F) and the slow one was slower than industrial UO2 microparticles (Type 
S). As a conclusion, results of the present study demonstrated the specificity of 
uranium nanoparticles biokinetic and confirmed the necessity of experimental 
studies to better characterise rapid and slow phases of lung clearance of ultrafine 
UO2 particles.
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The novel approach for assessing organ doses 
from paediatric CT scans in EPI-CT
Thierry-Chef, Isabelle1; Lee, Choonsik2; Jahnen, Andreas3; Dabin, Jérémie4;  
Friberg, Eva Godske5; Johannes, Hermen3; Istad, Tore Sivert5; Krille, Lucian6;  
Maccia, Carlo7; Nordenskjöld, Arvid8; Olerud, Hilde5; Rehel, Jean-Luc9;  
Struelens, Lara4; Kesminiene, Ausrele1
1 International agency for Research on cancer, FRaNce; 2 National cancer Institute, National Institutes of Health, USa; 
3 centre de Recherche Public Henri Tudor, LUXeMBOURG; 4 Studiecentrum voor Kernenergie – centre d’etude de 
l’energie Nucléaire, BeLGIUM; 5 Norwegian Radiation Protection authority, NORWaY; 6 Universitätsmedizin der 
Johannes Gutenberg-Universität Mainz, GeRMaNY; 7 centre d’assurance de qualité des applications Technologiques 
dans le domaine de la Santé, FRaNce; 8 Karolinska Institutet Karolinska University Hospital, SWeDeN; 9 Institut de 
Radioprotection et de Sûreté Nucléaire, FRaNce
The worldwide increasing use of paediatric computed tomography (CT) has led to 
increasing concerns regarding the subsequent effects from exposure to ionizing 
radiation. Several studies of CT use in children have been initiated, including 
recent study by Pearce et al. Availability of accurate and valid estimates of organ-
specific doses is essential for quantifying the cancer induction rate per unit 
dose delivered to the organ. The absorbed organ dose from a CT scan depends 
on factors such as age, sex, examination type, and calendar period of scan. This 
information is available from Radiology Information System (RIS) and is used 
in the ongoing studies. However, individual dosimetry in CT scanning is more 
complex and a broad variety of technical parameters used to adapt the scanner 
settings to each specific scan has to be taken into account.
In the Epidemiological study to quantify risks for paediatric computerized 
tomography and to optimise doses (EPI-CT), the dosimetric data collection is split 
into 2 periods – before and after introduction of Picture Archiving Computerized 
System (PACS). For the distant past, only sparse information about scanner 
settings and technical parameters can be obtained. A patchwork approach will be 
used to retrieve information from a specially developed questionnaire, surveys, 
scientific publications, expert interviews and interpolations. For the recent 
years, scanner settings (such as mAs kVp, etc.) will be extracted from the Digital 
Imaging and Communications in Medicine (DICOM) headers. In the EPI-CT 
study, individual organ doses will be estimated for each child. Radiation fields 
will be simulated together with X-ray interactions with the body using a series of 
phantoms of various ages and Monte-Carlo software. Uncertainty analyses will 
be conducted and maximum likelihood functions will be derived from available 
data to provide distributions of doses.
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ProCardio: Cardiovascular risk from exposure 
to low dose and low dose rate radiation
Atkinson, Michael John; presenting on behalf of the ProCardio consortium
Institute of Radiation Biology, Helmholtz Zentrum München, GeRMaNY
ProCardio is a medium-scale collaborative project funded by EURATOM Fission. 
There are 12 participating institutions, representing 8 European countries and 
Russia. 
Our project goals are:
•	 To understand the biological processes involved in the evolution of damage 
to the heart and blood vessels that follows exposure to low doses and low 
dose rates of ionizing radiation. 
•	 To identify novel biomarkers of exposure tof the cardiovasculature.
•	 To apply these biomarkers in a large-scale molecular epidemiological 
study following cardiovascular status in a four-nation cohort of childhood 
cancer survivors. 
•	 To construct biological-mathematical models of the cardiovascular effects of 
radiation, and to apply these models to the molecular epidemiologicaldata.
There are six scientific workpackages:
•	 Epidemiological and dosimetric studies on survivors of childhood cancer.
•	 Analysis of the effects of radiation quality on the cardiovascular system.
•	 Effects of low dose rates on development of cardiovascular disease.
•	 Tissue-level interactions in radiation-induced cardiovascular disease
•	 Identification of biomarkers.
Details of the consortium, the experimental strategy, and our latest results are 
available from the project website www.procardio.eu.
The annual scientific meeting of ProCardio will be held jointly with that 
of the CEREBRAD consortium, Tarragona, Spain, October 22 – 26, 2012. Please 
contact the management team (www.gabo-mi.com) or coordinator for details 
(atkinson@helmholtz-muenchen.de).
Acknowledgements: ProCardio is funded by the European Seventh Framework 
Programme under grant agreement No. 29523.
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Department of Radiation Sciences  
at the Helmholtz Zentrum München
Atkinson, Michael John1; Hoeschen, Christoph2; Jacob, Peter3; Zitzelsberger, Horst4
1 Institute of Radiation Biology, 2 Research Unit Medical Radiation Physics and Diagnsotics, 3 Institute of Radiation 
Protection and 4 Research Unit Radiation cytogenetics, Helmholtz Zentrum München, GeRMaNY
The mission of the Department of Radiation Sciences is to undertake fundamental 
and applied research to “optimise the benefits from the applications of ionizing 
radiation, whilst protecting against possible damage”.
Our research portfolio is based upon three columns: 
•	 Environmental Radioecology and Dosimetry
•	 Radiation and Risk
•	 Medical applications of ionizing radiation.
The DRS is a member of MELODI, as well as a participant in the DoReMi 
network of excellence. We are partners in a number of EURATOM collaborative 
projects investigating risks at low doses, including EpiRadBio, MSCT, ProCardio 
and STORE.
Information on the activities of the DRS, a descriptive brochure and details 
of the individual scientists involved is available from the DRS public web site 
(www.helmholtz-muenchen.de/en/drs/home/index.html).
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Epidemiological study on cancer and non-cancer 
incidence among Bulgarian medical radiogenic workers
Chobanova, N.
NcRRP – National centre of Radiobiology and Radiation Protection, Sofia, BULGaRIa
To contribute the cancer and non-cancer incidence estimate in relation to work 
history (years of first employment, duration of occupational exposure, radiation 
doses received for whole period) in a cohort of medical radiation workers. 
A retrospective cohort study was carried out. The cancer incidence among 
315 medical workers was compared with that of 320 other medical specialists 
who worked in hospitals on the territory in Sofia for period 1960 – 2000. Data 
concerning incident cancer and non-cancer occurrence was obtained from 
questionnaire. Data for individual doses were extracted from National System 
of Individual Dosimetric Control. Descriptive statistics, X2, Fisher’s exact test, 
ANOVA analyses were used. 
Cancer incidence was more frequently diagnosed among radiation workers 
compared to other medical specialists. When analyzing by cancer type the 
results were the same. No statistically significant difference in the non – cancer 
incidences between cases and controls has been observed. No statistically 
significant relation was observed between cumulative radiation dose and cancer 
incidence, or non-cancer incidence. No statistical significance was found between 
the year of first employment and cancer development for cases and for controls 
as well as and non-cancer incidence. It was not established statistical correlation 
between work duration in an ionizing radiation environment and appearance 
of cancer or non-cancer.
The present study shows that cumulative dose obtained and the duration 
of work in an ionizing radiation environment does not substantially influence 
the arising of cancer and non-cancer. Although we find higher degree of cancer 
occurrence among cases compared to controls, those two factors do not give us 
ground to confirm that work in an ionizing radiation sphere increases the cancer 
incidence.
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The EURADOS European Radiation 
Dosimetry Group Network
Rühm, Werner1; Alves, Joao2; Bottollier-Depois, Jean-Francois3; d’Errico, Francesco4;  
Fantuzzi, Elena5; Lopez, Maria-Antonia6; Miljanic, Saveta7; Olko, Pavel8; 
Schuhmacher, Helmut9; Stadtmann, Hannes10; Tanner, Rick11; Vanhavere, Filip12
1 HMGU, Neuherberg, GeRMaNY; 2 ITN, Sacavem, PORTUGaL; 3 IRSN, Fontenay-aux-Roses cedex, FRaNce;  
4 USP, Pisa, ITaLY; 5 eNea, Bologna, ITaLY; 6 cIeMaT, Madrid, SPaIN; 7 RBI, Zagreb, cROaTIa; 8 IFJ, Krakow, POLaND;  
9 PTB, Braunschweig, GeRMaNY; 10 SL, Seibersdorf, aUSTRIa; 11 HPa, Oxford, UK; 12 ScKceN, Mol, BeLGIUM
EURADOS, the European Radiation Dosimetry Group (www.eurados.org), 
represents a network of more than 50 European institutions and 200 scientists. 
EURADOS promotes, as a non-profit organization, research and development 
and European cooperation in the field of the dosimetry of ionizing radiation, 
and maintains a network which includes experts from reference and research 
laboratories, regulatory bodies and dosimetry services. Main aims of EURADOS 
are coordination of research and dissemination of scientific knowledge. 
EURADOS organizes Winterschools, Symposia and Workshops, Inter-
comparisons and Training Courses. Areas of activity include individual monitoring 
for external and internal exposure, retrospective dosimetry, environmental 
radiation monitoring, diagnostic and interventional radiology, nuclear medicine 
and radiation therapy, and computational dosimetry. The paper gives a brief 
overview on the EURADOS network. Special emphasis is placed on areas relevant 
for the MELODI low-dose radiation research including, for example, doses 
from incorporated radionuclides in Working Group WG7 with emphasis on 
studies of microdosimetry of internal emitters; computational methods applied 
to dosimetry in WG6; markers of exposure at low levels of dose in WG10; and 
quantification of out-of-field peripheral doses for second cancer risk estimates 
following radiotherapy (WG9).
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The DoReMi Network of Excellence is supporting 
the creation of the MELODI platform 
Salomaa, Sisko 
STUK – Radiation and Nuclear Safety authority, Helsinki, FINLaND
The aim of the DoReMi consortium is to promote the sustainable integration of low 
dose risk research in Europe. This will facilitate efforts to resolve the key policy 
questions identified by the ‘High Level Expert Group (HLEG) on Low Dose Risk 
Research’ (www.hleg.de). These are the shape /s of cancer dose-risk relationship /s, 
variation in risk between individuals, differences in tissue sensitivities for 
cancer, effects of radiation quality, risks from internal exposures and the risks 
of non-cancer effects. DoReMi provides an operational tool to continue the 
development of the MELODI platform (Multidisciplinary European Low Dose 
Risk Research Initiative) that represents the major national bodies and research 
programmes with a long term commitment to low dose risk research in Europe. 
Strategic planning of DoReMi activities is carried out in close collaboration with 
MELODI.
Since the beginning of the DoReMi Network of Excellence in January 
2010, there has been rapid progress in the establishment of a European research 
platform to focus on questions of low dose risk. DoReMi continues the initial work 
of HLEG by contributing to the development of the long-term SRA of MELODI, 
and by establishing the more detailed shorter-term DoReMi TRA. Engaging the 
broader scientific community via exploratory workshops has proven to be an 
efficient way in developing the research agendas. The research agendas provided 
by MELODI and DoReMi have helped to identify priorities for low dose risk 
research not only by the organisations involved but also in national, European 
and global contexts. 
DoReMi has implemented research programs addressing the three key 
research areas: shape of dose-response curve for cancer, individual radiation 
sensitivity for cancer and non-cancer effects. The research activities are all 
performed at appropriately low doses. DoReMi defines these low doses as those 
of 100 mGy or less. Low dose rates are defined as 0.1 Gy / h or less for low 
LET radiations. For high-LET radiations, dose and dose-rates of interest are 
lower, e.g. for alpha radiation by an order of magnitude. Low dose studies 
are complemented by higher dose / dose-rate studies to inform judgments on 
extrapolation from moderate and high doses /dose-rates to low doses / dose-rates. 
All RTD activities address the cross-cutting issues of radiation quality, tissue 
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sensitivity and internal emitters. During the first 18 months, several workshops 
were convened to develop strategies that focus on the most promising lines of 
research for the three areas. Experimental programs have been launched in 
all three areas, including a number of feasibility studies preparing the field for 
large international collaborative efforts. The RTD approaches have been closely 
coordinated through discussions on needs for research infrastructures and 
analytical platforms, as well as targeted stimulation of training and education 
of next-generation researchers at the European level. 
The planned duration of DoReMi is 2010 – 2015. Despite the wide exper-
tise available within DoReMi since its beginning, it has been quite clear that 
the emerging research needs also require competence and resources not avail-
able within the initial consortium. Therefore it was expected that DoReMi will 
be enlarged during the course of the project and additional beneficiaries join the 
consortium. To date, two competitive calls for new partners have been organ-
ised: first one in 2010, with ten new beneficiaries joining the consortium and 
the second one in 2012, again with ten new (potential) beneficiaries (expected 
to join 1 January 2013, subject to successful negotiations and EC approval). The 
competitive calls have enhanced the competence of the consortium in several 
key areas, by integrating research experts in biomarker identification, immu-
nological / inflammatory pathways, the effects of chronic low dose exposures, 
vascular effects, lens opacities, epigenetics and novel approaches on studies on 
DNA lesions and their consequences.
list of DoreMi organisations in 2012
no Beneficiary name Beneficiary 
short name
Country Date enter 
project
Date exit 
project
1 Radiation and Nuclear Safety Authority STUK Finland 1 72
2 Institut de Radioprotection et de Sûreté Nucléaire IRSN France 1 72
3 Helmholz Zentrum München HMGU Germany 1 72
4 Commissariat à l’Energie Atomique CEA France 1 72
5 Health Protection Agency HPA UK 1 72
6 University of Pavia UNIPV Italy 1 72
7 Istituto Superiore di Sanitá ISS Italy 1 72
8 Belgian Nuclear Research Centre SCKCEN Belgium 1 72
9 Bundesamt für Strahlenschutz BfS Germany 1 72
10 University of Stockholm SU Sweden 1 72
11 Centre for Research in Environmental Epidemiology CREAL Spain 1 72
12 Institut Curie IC France 1 72
13 Universitaetsklinikum Erlangen UKER Germany 19 72
14 Johann Wolfgang Goethe Univer-
sitaet, Frankfurt am Main
GUF Germany 19 72
15 Universitaet Rostock UROS Germany 19 72
16 Norwegian University of Life Sciences UMB Norway 19 72
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no Beneficiary name Beneficiary 
short name
Country Date enter 
project
Date exit 
project
17 Norwegian Radiation Protection Authority NRPA Norway 19 72
18 Nasjonalt Folkehelseinstitutt NIPH Norway 19 72
19 Agenzia Nazionale per le Nuove Tecnologie, 
l’Energia e lo Sviluppo Economico Sostenibile
ENEA Italy 19 72
20 Institute for Environmental Sciences IES Japan 19 72
21 Dublin Institute of Technology DIT Ireland 19 72
22 Erasmus Universitair Medisch Centrum Rotterdam Erasmus MC The Nether-
lands
19 72
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